Home
  >  
Section 35

EurekaMag Full Text Articles Chapter 34,718



References:

Scenna, F.N.; Hockett, M.E.; Blackmon, H.E.; Schrick, F.N. 2002: Development of in vivo-derived bovine embryos cultured with prostaglandin F2alpha. Theriogenology 57(1): 512
Sood, A.; Panchagnula, R. 1999: Development of in-vitro dissolution test for oral solid dosage forms of nifedipine using sodium lauryl sulphate. Journal of Pharmacy and Pharmacology 51(Suppl ): 302
Sivakumar, M.R.; Bacon, P.A.; Misra, R.N.; Krishnamurthy, V.; Bambery, P. 2003: Development of index to assess disease activity in Takayasus arteritis. Kidney and Blood Pressure Research 26(4): 289-290
Moffett, M.F.; Detenbeck, N.E.; Jicha, T.M.; Elonen, C.M.; Anderson, L.E.; Taylor, D.L.; Snarski, V.M.; Simon, T.P. 2001: Development of indicators of exposure and response to sediment and habitat alteration in Lake Michigan coastal riverine wetlands. IAGLR Conference Program and Abstracts 44: 94
Zenetos, A.; Streftaris, N. 2002: Development of indicators towards sustainable aquaculture in European scale. Journal of Fish Biology 61(Suppl A): 260
Cheng, R.; Lin, B.; Ortwerth, B.J. 2001: Development of individual yellow chromophores and fluorophores in human lens with age. IOVS Investigative Ophthalmology and Visual Science 42(4): S290
Monroe, D.G.; Johnsen, S.A.; Getz, B.J.; Khosla, S.; Riggs, B.L.; Spelsberg, T.C. 2002: Development of inducible estrogen receptor-alpha and -beta osteoblastic cell lines to examine differential estrogen regulation. Journal of Bone and Mineral Research 17(Suppl 1): S437
Duman, R.S.; Sakai, N.; Chen, J.S.; Zhang, Y.J.; Stephen, C.; Nestler, E.J. 1999: Development of inducible, tissue-specific dominant negative CREB transgenic mice. Society for Neuroscience Abstracts 25(1-2): 422
Papaligoura, Z.; Panopoulou Maratou, O.; Solman, M.; Arvaniti, K. 2001: Development of infants conceived after intracytoplasmic sperm injection. Human Reproduction 16(Abstract Book 1): 83
Amemiya, K.; Semino Mora, C.; Granger, R.; Wahl, S.M.; Dalakas, M.C. 1999: Development of inflammatory myopathy in the TGF-beta1 knockout mice Characterization of the disease and attenuation after treatment with fibronectin peptides. Neurology 52(6 Suppl 2): A448
Fervers, B.; Demma, F.; Dilhuydy, J.; Douiller, A.; Farsi, F.; Saltel, P.; Sandrin Serthon, B.; Delavigne, V.; Philip, T. 1999: Development of information sources for cancer patients based on clinical practice guidelines and patient needs. European Journal of Cancer 35(Suppl 4): S279
IInuma, M.; Harauchi, H.; Umeda, T.; Hiroko, K.; Inamura, K.; Takemura, A. 2000: Development of infrastructure for bidirectional data conversion and two dimensional data structure in the linkage of plural radiotherapy facilities with integrated multi-institutional radiation oncology database. Lemke, Heinz U Author, Inamura, Kiyonari Author, Doi, Kunio Author, Vannier, Michael W Author, Farman, Allan G Author International Congress Series CARS : Computer Assisted Radiology and Surgery 673-678
Tanaka, Y.; Takahashi, T. 2001: Development of injection technology for uniform dispersion of brine or seasoning liquid in meat processing. Nippon Shokuhin Kagaku Kogaku Kaishi 48(10): 705-711
Borovik, A.S.; Padden, K.M. 2001: Development of inorganic/organic materials for the storage and release of nitric oxide. Abstracts of Papers American Chemical Society 222(1-2): INOR208
Ding, P.; Fuchigami, L.H.; Plant, T.K. 2003: Development of instant chlorophyll and nitrogen diagnostic system for intact plant leaves. HortScience 38(5): 694
Jones, S.J.; Roeber, R.L. 2001: Development of instructional materials for CD-rom and the internet, the beef myology and muscle profiling project. Journal of Dairy Science 84(Suppl 1): 175-176
Clark, S.J.; Shojaee Moradie, F.; Croos, P.; Jackson, N.C.; Umpleby, A.M.; Wendon, J.A. 1999: Development of insulin insensitivity in acute liver failure. Hepatology 30(4 Part 2): 168A
Kumar, N.; Khurana, A.; Dey, C.S.nkar 2001: Development of insulin non-responsiveness in skeletal muscle cell line. FASEB Journal 15(4): A207
Oshikawa, J.; Toya, Y.; Otsu, K.; Hankins, R.; Tsunematsu, T.; Minamisawa, S.; Umemura, S.; Hagiwara, Y.; Ishikawa, Y. 2004: Development of insulin resistance in caveolin-3 knockout mice. FASEB Journal 18(4-5): Abstract 734
Yamamoto, A.; Nakano, S.; Takeda, I.; Kumada, T.; Kiriyama, S.; Sone, Y. 2003: Development of insulin-dependent diabetes mellitus after acute pancreatitis Case report. Pancreas 26(4): 398
Kingzett, B. 2002: Development of intensive deepwater oyster culture systems in British Columbia. Journal of Shellfish Research 21(1): 312
Sorokin, I.; Galchenko, N.; Galchenko, V.F. 2003: Development of interactive identification system of unique and extremophilic microorganisms SINIDEM in internet. FEMS Congress of European Microbiologists Abstract Book 1: 176
Whitworth, R.H.; Mcclugage, S.G. 2000: Development of interactive program to facilitate understanding of sequelae of lesions of the brachial plexus. FASEB Journal 14(4): A310
Skipper, P.L.; Hughey, B.J.; Liberman, R.G.; Wishnok, J.S.; Klinkowstein, R.E.; Shefer, R.E.; Tannenbaum, S.R. 2002: Development of interfaces for direct analysis of isotopes by accelerator mass spectrometry. Proceedings of the American Association for Cancer Research 43: 387
Bosmans, Jean L.; Woestenburg, Annemie; Heuvels, Jorge; Ysebaert, Dirk K.; Corthouts, Robert; Van Marck, Eric A.; De Broe, Marc E.; Verpooten, Gert A. 1999: Development of interstitial fibrosis and arteriosclerosis in cadaveric renal allografts Results from a prospective clinicopathological study. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 753A-754A
Yokota, A.; Tanaka, A.; Takeuchi, K. 2004: Development of intestinal but not gastric lesions induced by rofecoxib in the presence of a low dose of indomethacin. Journal of Pharmacological Sciences 94(Suppl 1): 256P
Tiniakos, D.; Stavrakis, S.; Anagnostou, V.; Karandrea, D.; Agapitos, E.; Kittas, C. 2003: Development of intrinsic innervation in human fetal kidney. Virchows Archiv 443(3): 252
Pugh, P.J.; Jones, R.D.; Jones, T.H.; Channer, K.S. 2001: Development of intrinsic tone in rat coronary arteries in-vitro. Clinical Science (London) 101(2): 4P
Emmert, J.; Barnes, D. 1999: Development of introductory animal and poultry science courses for distribution over the internet. Poultry Science 78(Suppl 1): 45
LiYuLian; ZhouRongHua; Branlard,G.; JiaJiZeng 2010: Development of introgression lines with 18 alleles of glutenin subunits and evaluation of the effects of various alleles on quality related traits in wheat. Journal Of Cereal Science: 1, 127-133
Bai, L.; Burman, S.; Gledhill, L. 2000: Development of ion exchange chromatography methods for monoclonal antibodies. Journal of Pharmaceutical and Biomedical Analysis 22(3): 605-611
Holbrey, J.D.; Reichert, W.M.; Turner, M.B.; Green, K.; Rogers, R.D. 2003: Development of ionic liquids containing environmentally acceptable and sustainable components. Abstracts of Papers American Chemical Society 226(1-2): IEC 128
Lakey, J.R.T.; Shapiro, A.M.J. 2003: Development of isolation protocols for clinical islet transplantation. Diabetes and Metabolism 29(Hors serie 2): 4S93
Van Dyke, M.E.; Siller Jackson, A.J. 2002: Development of keratin coatings for osteoinduction on titanium. Abstracts of Papers American Chemical Society 224(1-2): PMSE 100
Smith; Lemon; Erb; Erb-Downward; Downward; Ulrich; Wittliff 1999: Development of Kinetic Ligand-binding Assays Using a Fiber Optic Sensor. Clinical Chemistry 45(9): 1683-1685
Bates, M.D.; Persons, D.A.; Schatzman, L.C.; Harvey, R.P.; Potter, S.S. 2000: Development of knockout mesenchymal cell lines and expression vectors to identify HLX homeobox transcription factor downstream target genes. JPGN 31(Suppl 2): S43
Sundin, G.W. 2003: Development of laboratory models of the phyllosphere environment What works and what doesnt. Phytopathology 93(6 Suppl): S106
Iwami, N.I.; Komatsu, H.; Onuma, K.; Takai, T.; Inamori, Y.I. 2003: Development of lake water renovation technology using absorption type phosphorus removal recycling system. IAGLR Conference Program and Abstracts 46: 276
Shafri,H.Z.M.; Zahidi,I.M.; Bakar,S.A. 2010: Development of landslide susceptibility map utilizing remote sensing and Geographic Information Systems. Disaster Prevention and Management: 1, 59-69
Franz, K.J.; Nitz, M.; Lukovic, E.; Imperiali, B. 2003: Development of lanthanide-binding peptides as natively expressed protein probes. Journal of Inorganic Biochemistry 96(1): 131, 15 July
Franz, K.J.; Nitz, M.; Imperiali, B. 2002: Development of lanthanide-binding polypeptides as natively expressed protein probes. Abstracts of Papers American Chemical Society 224(1-2): INOR 259
Kato, K.; Kaneko, T.; Fujita, K.; Smith, N.; Nakamura, O.; Takamatsu, T.; Kawata, S. 2001: Development of laser processing technology for living cells with a near-infrared ultra-short pulsed laser. Cell Structure and Function 26(5): 469
Cowell, P.E.; Denenberg, V.H. 2002: Development of laterality and the role of the corpus callosum in rodents and humans. Rogers, Lesley J, Andrew, Richard J Comparative vertebrate lateralization 274-305
Shimizu, M. 2000: Development of latex agglutination test for the detection of Echinococcus multilocularis coproantigens in the definitive hosts. Japanese Journal of Veterinary Research 48(1): 68-69
Ito, H.O.; Nokihara, K.; Toda, C.; Soutome, S.; Sato, S.; Yamamoto, S.; Inoue, M. 2002: Development of lead compounds focusing on prevention of infective endocarditis using combinatorial peptide libraries. Journal of Peptide Science 8(Suppl): S150
Kumar, P.M.P.atheesh; Maji, M.D.; Gangwar, S.K.; Das, N.K.; Saratchandra, B. 2000: Development of leaf rust and dispersal of urediniospores in mulberry. International Journal of Pest Management 46(3): 195-200
Perez,C.; Castro,R.de; Simons,D.; Gimenez,G. 2010: Development of lean supply chains a case study of the Catalan pork sector. Supply Chain Management: An International Journal: 1, 55-68
Enriguez Sarano, M.L.; Bellamy, M.; Basmadjian, A.; Messika Zeitoun, D.; Capps, M. 2003: Development of left ventricular remodeling in Mitral Regurgitation Influence of etiology and treatment. Journal of the American College of Cardiology 41(6 Suppl A): 505A
Van Baren, P.; Knopjes, S.; Voorhout, G.; Kerkhof, P. 1999: Development of left ventricular size in foals as a function of growth. Journal of Molecular and Cellular Cardiology 31(6): A107
Khumalo, N.P.; Huson, S.; Burge, S. 2001: Development of lentigines within naevoid hypopigmentation. British Journal of Dermatology 144(1): 188-189
Tai, C.K.; Shichinohe, T.; Nishida, M.; Hegerich Gilliam, S.; Bochner, B.H.; Kasahara, N. 2000: Development of lentiviral vectors for anti-angiogenic gene therapy. Cancer Gene Therapy 7(12): S15
Tonn, T.; Herder, C.; Becker, S.; Luetzenkirchen, K.; Grez, M.; Seifried, E. 2001: Development of lentiviral vectors for gene therapy of hemophilia A. Annals of Hematology 80(Suppl 1): A65
D.P.scalis, R.; Iwahashi, M.; Tamura, M.; Padlan, E.; Gonzales, N.; Santos, A.; Giuliano, M.; Schuck, P.; Schlom, J.; Kashmiri, S. 2002: Development of less immunogenic antibodies derived from an anti-carcinoma antibody reactive against carcinoembryonic antigen. Proceedings of the American Association for Cancer Research 43: 1016-1017
Lin, C.C.; Tam, R.; Orr, R.; Hong, Z.; Lau, J.Y. 2001: Development of levovirin as a second generation ribavirin for the treatment of chronic hepatitis C. Gastroenterology 120(5 Suppl 1): A 569
Canney, D.J.; Zhao, C.; Zhang, M.; Sun, W.; Hightower, C.; Caldwell, W.S.; Bencherif, M.; Sadieva, K.; Gabriel, J.L. 2001: Development of ligands for neuronal nicotinic receptors Synthesis and evaluation of 2-substituted quinuclidines. Abstracts of Papers American Chemical Society 222(1-2): MEDI43
Roldan, G.; Ruiz, E. 2001: Development of limnology in Colombia. Wetzel, Robert G, Gopal, Brij Limnology in Developing Countries 69-119
Chaloupka, E.C.; Kang, J.; Mastrangelo, M.A.; Angelucci, J.; Martz, W.P. 1999: Development of linear regression equations to predict maximal anaerobic power in adolescent males. Medicine and Science in Sports and Exercise 31(5 Suppl): S77
Zant-Przeworska, E.; Kamps, J.A.A.M.; Roks, A.J.M.; Gilst, W.H.; Scherphof, G.L. 2002: Development of liposomal gene targeting for therapeutic intervention or prevention of restenosis. Cellular and Molecular Biology Letters 7(2): 268-269
Zhou, S.Ningsun.; Reiner, E.J.; Marvin, C.; Helm, P.; Riddell, N.; Dorman, F.; Misselwitz, M.; Shen, L.; Crozier, P.; Macpherson, K.; Brindle, I.D. 2010: Development of liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry for analysis of halogenated flame retardants in wastewater. Analytical and Bioanalytical Chemistry 396(3): 1311-1320
Gray, M.J.; Chang, D.; Zhang, Y.; Liu, J.; Bensoussan, A. 2010: Development of liquid chromatography/mass spectrometry methods for the quantitative analysis of herbal medicine in biological fluids: a review. Biomedical Chromatography: Bmc 24(1): 91-103
Grumbach, N.M.; Mylonakis, E.; Wing, E.J. 1999: Development of listerial meningitis during ciprofloxacin treatment. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 29(5): 1340-1341
Wang, L.; Shankar, V.; Kochanek, S.; Qian, C.; Prieto, J. 2002: Development of liver specific and regulatable adenoviral vector for gene therapy. Journal of Hepatology 36(Suppl 1): 27
Gabriela Kramer, M.; Wu, C.; Prieto, J.; Fortes, P. 2001: Development of liver specific promoters for targeted gene therapy. Journal of Hepatology 34(Suppl 1): 219
D'a D.B.ito, C.F.; Andrade, D.R.; Matsudo, S.M.M.; Matsudo, V.K.R. 2000: Development of local body fat from puberty to adulthood. Medicine and Science in Sports and Exercise 32(5 Suppl): S356
Hall, C.B.; Stevens, T.P.; Swantz, R.J.; Sinkin, R.A.; McBride, J.T. 1999: Development of local guidelines for prevention of respiratory syncytial viral infections. Pediatric Infectious Disease Journal 18(10): 850-853
Krebs, B.; Fischer, M.R.; Albrich, W.C.; Gaertner, R. 2001: Development of locally adapted recommendations for antibiotic therapy? Data ascertainment and acceptance. Infection 29(Suppl 1): 11
Hwang, Y.S.; Chmielewski, J. 2005: Development of low molecular weight HIV-1 protease dimerization inhibitors. Journal of Medicinal Chemistry 48(6): 2239-2242
Guo, Z.; Ma, J.; Adams, A.; Gallo, J.M. 1999: Development of low molecular weight cytotoxic conjugates targeted to peripheral benzodiazepine. Proceedings of the American Association for Cancer Research 40: 585
Ruoff, J.M.; Hu, P.; Khawli, L.A.; Epstein, A.L. 1999: Development of low-toxicity IL-2 analogs for the immunotherapy of solid tumors. Proceedings of the American Association for Cancer Research 40: 76
Liu, Y.I.; Abaibou, H.; Fletcher, H.M. 1999: Development of luciferase luxAB and xylosidase/arabinosidase XA genes as reporter genes for Porphyromonas gingivalis. Abstracts of the General Meeting of the American Society for Microbiology 99: 33
Brandenburg, V.M.; Fassbender, W.J.; Ketteler, M.; Floege, J.; Ittel, T.H. 2002: Development of lumbar bone mineral density in the late course following kidney transplantation. Journal of Bone and Mineral Research 17(Suppl 1): S488
Carmona-Soria, I.; Jiménez-Sáenz, M.; González-Vilches, J.; Herreriás-Gutiérrez, J.M. 2001: Development of lupic anticoagulant during combination therapy in a patient with chronic hepatitis C. Journal of Hepatology 34(6): 965-967
Gunnarsson, I.; Nordmark, B.; Bakri, A.H.; Grondal, G.; Larsson, P.; Klareskog, L.; Ringertz, B. 1999: Development of lupus-related side-effects in patients with early RA during treatment with sulphasalazine The role of IL-10 and HLA. Arthritis and Rheumatism 42(9 Suppl): S102
Kim, Y.J.; Brutkiewicz, R.; Broxmeyer, H. 2002: Development of lymphokine activated killer-like cells from cord blood cytotoxic T lymphocytes by 4-1BB co-stimulation. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 60
Shah, N.; Thapar, N.; Ramsay, A.; Murch, S.; Meadows, N.; Lindley, K.J.; Milla, P.J. 2001: Development of lymphoma in intractable enterocolitis of infancy. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 374
Szidonya, E.; Jamieson, J. 2000: Development of macromolecular acceptors for ST6GlcNAc I from bovine glycoproteins. Glycobiology 10(10): 1097
Bae, E.; Baek, H.J.; Seoug, H.S.; Kwon, I.C. 2000: Development of macroporous chitosan bead for three dimensional cell culture. Tissue Engineering 6(6): 694
Wofford, B.; Botten, J.; Ricci, R.; Mirowsky, K.M.; Hjelle, B. 2002: Development of major histocompatibility complex-homozygous deer mice A generalized method to produce immunologically matched cohorts from outbred populations. Journal of Investigative Medicine 50(1): 47A
Fedorovska, J.A.; Zhivitsky, Z.N. 1999: Development of male gametophyte of Larix decidua Mill in the conditions of West Ukraine. Acta Biologica Cracoviensia Series Botanica 41(Suppl 1): 38
Lai, M-Yu.; Yang, W-Chang.; Lin, C-Ching. 2004: Development of malignancy after treatment of idiopathic membranous nephropathy. Kidney International 66(1): 464; Author Reply 464-5
Wayte, Jeremy, R.T. 2001: Development of mammalian cell culture bioreactor processes Increasing productivity and process robustness. Abstracts of Papers American Chemical Society 221(1-2): BIOT 152
Barry, D.M.; Herhlodt, G.; Visser, A.; Hzimhanovich, B.B.; Godke, R.A. 2003: Development of mammalian embryos and stem cells at micro-gravity conditions at the International Space Station. Theriogenology 59(1): 337
Heidenreich, M.C.; Heidenreich, G.E.; Turechek, W.W. 2001: Development of management strategies for control of bacterial diseases of stone fruit in New York. Phytopathology 91(6 Suppl): S37-S38
Travnichek, V.H. 2003: Development of management strategies for producing trophy flathead catfish in the lower Missouri River. American Fisheries Society Annual Meeting 133: 335
Poetter, K.; Toohey, B.; Foote, S. 2000: Development of mass spectrometry as a mutation detection tool. Biochemical Society Transactions 28(5): A150
Welker, P.; Lelke, A.; Guhl, S.; Nordheim, R.; Henz, B.M.; Zuberbier, T. 1999: Development of mast cells from human umbilical cord blood in children with atopic and non-atopic parents. Journal of Allergy and Clinical Immunology 103(1 Part 2): S40
Koroleva, S.V.; Ashmarin, I.P. 2000: Development of mathematical model and software for estimation of regulatory peptide complexes influence on organism. Regulatory Peptides 94(1-3): 14, 25 October
Lee, B.I.; Lee, J.S.; Choi, H.K.; Lee, D.S. 2003: Development of measurment method of regional myocardial contractility using gated myocardial SPECT. Journal of Nuclear Medicine 44(5 Suppl): 255P-256P
Takayasu, M.; Kuwahara, T.; Ogawa, S.; Saito, K.; Katagiri, T. 2001: Development of medical equipment for longer healthy life. Japanese Journal of Artificial Organs 30(3): 77-86
Brochez, L.; Naeyaert, J.M. 2002: Development of melanoma What does epidemiology teach us?. Pigment Cell Research 15(Suppl 9): 23
Frohme, M.; Klopp, J.; Schwarz, M.; Beissbarth, T.; Hoheisel, J.; Radeke, H.H. 2003: Development of membrane and glass cDNA arrays for the analysis of genes involved in renal inflammatory migration. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R122
Groth, T.; Krasteva, N.; Seifert, B.; Albrecht, W.; Malsch, G.; Altankov, G.; Paul, D. 2002: Development of membranes for bioartificial liver support. International Journal of Artificial Organs 25(7): 692
Schuster, O.; Wiese, F. 2003: Development of membranes for medical separators. International Journal of Artificial Organs 26(7): 617
Simon, J.F.; Yuan, C.; Welch, P.G. 2003: Development of membranous lupus nephritis after immunization against Bacillus anthracis. Journal of the American Society of Nephrology 14(Abstracts Issue): 796A
An, J.; Lehman, D.; Newgard, C.B. 1999: Development of metabolic abnormalities in ZDF rats does not require induction of hepatic glucose-6-phosphatase. Diabetes 48(Suppl 1): A98
Bergmann, S.; Fietze, E.; Leenders, F.; Theuring, F.; Dietel, M.; Royer, H.D.eter 2002: Development of metastatic breast cancer in YB-1 transgenic mice. Proceedings of the American Association for Cancer Research 43: 313
Katoh, C.; Shiga, T.; Takano, A.; Morita, K.; Tsukamoto, E.; Tamaki, N. 2000: Development of method for high resolution imaging of cerebral glucose metabolism using FDG and three-dimensional dynamic PET. Journal of Nuclear Medicine 41(5 Suppl): 102P
Ben Rejeb, S.; Delahaut, P. 2003: Development of methodologies for the detection of biological agents possibly used for deliberate contamination of the food supply Screening techniques for domoic acid. Abstracts of Papers American Chemical Society 226(1-2): AGRO 68
Koseki, K.; Takahashi, S.; Koyama, T. 2003: Development of methodology for transmembrane movement studies of isoprenoid compounds. Journal of Molecular Catalysis B Enzymatic 22(3-4): 233-234, 2 June
Ezra,D.; Skovorodnikova,J.; Kroitor-Keren,T.; Denisov,Y.; Liarzi,O. 2010: Development of methods for detection and Agrobacterium-mediated transformation of the sterile, endophytic fungus Muscodor albus. Biocontrol Science And Technology: 1 2, 83-97
Liengjayetz, C.; Teerasukaporn, P. 2000: Development of methods for isolation and purification of phyllanthin from Phyllanthus amarus Schum and Thonn. Phytomedicine 7(Suppl 2): 81
Madariaga, A.; Hall, R.; Boland, G.J.; Pauls, K.P.; Michaels, T.E.; Robinson, R.A. 2001: Development of methods for screening bean for resistance to white mold de Bary. Canadian Journal of Plant Pathology 23(2): 201-202
Musselman, Ian J.; Al Shami, Rania; Farach Carson, Mary C.; Carson, Dan 2003: Development of methods to discriminate between OPN charge forms in biological fluids. FASEB Journal 17(4-5): Abstract 631
Sugio, Y.; Takahashi, K.; Moriguchi, H.; Isami, T.; Yasuda, K. 2002: Development of micro-multi-electrode array chip system for multi-site stimulation/analysis of nerve cells F network. Biophysical Journal 82(1 Part 2): 280a-281a
Rexroad, C.E.I.i; Keele, J.W. 2003: Development of microarrays for transcriptome research in rainbow trout. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 134A(Suppl 1): S29
Potier, M.C.; Gibelin, N.; Cauli, B.; Rossier, J. 2000: Development of microarrays to analyze gene expression in brain extracts of KO mice. European Journal of Neuroscience 12(Suppl 11): 173
Homann, M.J.; Previte, E.; Dodds, D.R. 1999: Development of microbial bioconversions for the synthesis of cholesterol absorption inhibitor SCH 58235. Abstracts of the General Meeting of the American Society for Microbiology 99: 497
Van Praag, E. 2001: Development of microbicides: WHO's perspective. Aids 15(Suppl 1): S80-S83
Chan, N.G.; Raty, S.; Zeringue, H.C.; Beebe, D.J.; Wheeler, M.B. 2001: Development of microfabricated devices for embryo production Embryo biocompatibility. Theriogenology 55(1): 332
Niwa, O.; Kurita, R.; Hayashi, K.; Torimitsu, K.; Maeyama, K.; Tanizawa, K. 2001: Development of microfabricated histamine biosensors. Japanese Journal of Pharmacology 85(Suppl 1): 11P
Iwaki, S.; Ohashi, Y.; Maeyama, K.; Kurita, R.; Niwa, O.; Tanizawa, K. 2000: Development of microfabricated histamine sensor using recombinant histamine oxidase and determination of histamine released from mast cells. Japanese Journal of Pharmacology 82(Suppl 1): 88P
Suzuki, A.; Ikeda, H.; Yoshiki, T. 2001: Development of microglia/macrophage encephalomyelopathy in transgenic rats carrying HTLV-1 LTR-env-pX gene. AIDS Research and Human Retroviruses 17(Suppl 1): S 47
Polyanskaya,L.M.; Gorbacheva,M.A.; Milanovskii,E.Yu.; Zvyagintsev,D.G. 2010: Development of microorganisms in the chernozem under aerobic and anaerobic conditions. Eurasian Soil Science: 3, 328-332
Zhang, Y.; Tang, Z.; Maroto Valer, M.M.; Andresen, J.M. 2003: Development of microporous activated carbons from unburned carbon in fly ash. Abstracts of Papers American Chemical Society 225(1-2): FUEL 32
Murch, S.J.; Chiwocha, S.D.S.; Saxena, P.K. 2002: Development of micropropagation technologies for St Johns wort Relevance on application. Rajasekaran, K , Reprint Author, Jacks, T J , Reprint Author, Finley, J W Crop biotechnology: 161-170
Mouri, H.; Edwards, K.J.; Goto Yamamoto, N. 1999: Development of microsatellite markers for grape. American Journal of Enology and Viticulture 50(2): 226-227
Steven, C.R.; Wilkes, J.; Place, A.R.; Hill, J.; Masters, B. 2003: Development of microsatellite markers in the blue crab, Callinectes sapidus. Journal of Shellfish Research 22(1): 356
Isoyama, T.; Kawano, S.; Arai, H.; Yambe, T.; Nitta, S.; Hashimoto, H.; Imachi, K. 2003: Development of miniature horizontally opposed type vibrating flow blood pump. International Journal of Artificial Organs 26(7): 622
Cunliffe, H.E.; Scherr, M.; Azorsa, D.O.; Anzick, S.L.; Rossi, J.J.; Meltzer, P.S. 2001: Development of model systems to specifically block AIB1-mediated gene expression in breast cancer cells containing AIB1 gene amplification. Proceedings of the American Association for Cancer Research 42: 269
Orth, H.M.; Kruger, K.D.; Schmoll, D.; Bornstein, S.R.; Scherbaum, W.A.; Joost, H.G.; Barthel, A. 2004: Development of model systems to study the signal transiduction of protein kinase B and the forkhead transcription factor FKHR. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R71
Alvarez-Guerra, M.; Ballabio, D.; Amigo, J.é M.; Bro, R.; Viguri, J.R. 2010: Development of models for predicting toxicity from sediment chemistry by partial least squares-discriminant analysis and counter-propagation artificial neural networks. Environmental Pollution 158(2): 607-614
Hassen, A.; Wilson, D.E.; Rouse, G.H.; Hays, C.L.; Amin, V.R. 1999: Development of models for prediction of percent intramuscular fat in live cattle. Journal of Animal Science 77(Suppl 1): 153
Smith, N.P.; Crampin, E.J. 2004: Development of models of active ion transport for whole-cell modelling: cardiac sodium-potassium pump as a case study. Progress in Biophysics and Molecular Biology 85(2-3): 387-405
Schinckel, A.P.; Einstein, M.E.; Herr, C.T.; Wang, Y.; Bowers, K.A.; Hankins, S.L.; Weber, T.E.; Richert, B.T. 2001: Development of models to describe the weekly response of ractopamine. Journal of Animal Science 79(Suppl 2): 54
Gans, H. 2002: Development of modern liver surgery. Lancet 360(9335): 805
Abe, K. 2002: Development of molecular and cell biology on taste signaling A new basis for design of food quality. Nippon Shokuhin Kagaku Kogaku Kaishi 49(5): 291-296
Daly, K.; Sharp, R.J.; Mccarthy, A.J. 1999: Development of molecular biological tools for monitoring sulfate - reducing bacteria in landfill sites. Abstracts of the General Meeting of the American Society for Microbiology 99: 485
Ueda, M.; Tanaka, A. 2001: Development of molecular breeding of yeast by cell surface engineering. Abstracts of Papers American Chemical Society 221(1-2): AGFD 89
Fry, H.C.; Karlin, K.D.; Hoertz, P.G.; Wong Verelle, D.; Meyer, G.J. 2002: Development of molecular catalysts for dehalogenation of some EPA contaminant list compounds. Abstracts of Papers American Chemical Society 224(1-2): ENVR 10
Hayden, D.M.; Christopher, D.A. 2002: Development of molecular genetic tools to control senescence in Anthurium. Plant Biology (Rockville) : 97
Aboagye, E.O. 2001: Development of molecular imaging paradigms. British Journal of Cancer 85(Suppl 1): 14
Reece, K.S.; Ribeiro, W.L.; Gaffney, P.M.; Pierce, J. 2000: Development of molecular markers for constructing a genetic linkage map of the eastern oyster Crassostrea virginica. Journal of Shellfish Research 19(1): 617
Gaston, S.M.; Siddiqui, M.; Soares, M.; Perides, G.; Upton, M.; Dewolf, W.C. 2002: Development of molecular markers for prostate cancer local T staging Capsular penetration positive, margin negative disease is associated with matrix metalloproteinases and collagen fragments on the external surface of the prostate gland. Journal of Urology 167(4 Suppl): 224
Mercer, C.F.; Barrett, B.; Griffiths, A.G.; Woodfield, D.R.; Moore, K. 2001: Development of molecular markers for resistance to clover root-knot nematode. Phytopathology 91(6 Suppl): S139
Sun, H.; Wang, H.Tao.; Kwon, W.Saeng.; In, J.Gyo.; Lee, B.Soo.; Yang, D.Chun. 2010: Development of molecular markers for the determination of the new cultivar 'Chunpoong' in Panax ginseng C. A. Meyer associated with a major latex-like protein gene. Biological and Pharmaceutical Bulletin 33(2): 183-187
Zhang, Y.; Stommel, J.R. 1999: Development of molecular markers linked to high pigment and dark green loci in tomato. HortScience 34(3): 449
Genger, R.K.; Brown, A.H.D.; Burdon, J.J. 2002: Development of molecular markers linked to scald resistance genes derived from wild barley, Hordeum vulgare ssp spontaneum. Phytopathology 92(6 Suppl): S28
Inoue, M. 1999: Development of monitoring system for water flow and solute transport in sandy soil and its application. Nihon Sakyu Gakkaishi 46(2): 71-75
Ugarte, S.D.; Seiden, L.S.; Vosmer, G.; Hormanics, G.E.; Hammond, D.L. 1999: Development of monoaminergic systems in the mouse is largely unaffected by knock-down of GABAA receptors. Society for Neuroscience Abstracts 25(1-2): 1789
Avalle, M.P.; Hook, R.R.; Mcclain, A.; Green, J.A.; Mathialagan, N.; Egodage, K.; Roberts, R.M. 2001: Development of monoclonal and polyclonal antibodies against bovine pregnancy-associated glycoproteins for use as reagents in localization of PAG expression and for pregnancy detection. Biology of Reproduction 64(Suppl 1): 341
Singh, G.; Truhan, M.; Aquino, A.; Carandang, M.; Pitts, R.; Ramirez, J.; Singh, S. 2002: Development of monoclonal antibodies against Toll-like receptors. FASEB Journal 16(4): A150
Swaczynova, J.; Lenobel, R.; Strnad, M. 2000: Development of monoclonal antibodies against meta-topolin and its 9-glycosides. Plant Physiology and Biochemistry (Paris) 38(Suppl): s89
MaXi; SunPeng; HePingLi; HanPengFei; WangJunJun; QiaoShiYan; LiDefa 2010: Development of monoclonal antibodies and a competitive ELISA detection method for glycinin, an allergen in soybean. Food Chemistry 1(2): 546-551
Leinonen, J.; Finne, P.; Zhang, W.M.; Stenman, U.H. 2000: Development of monoclonal antibodies and an assay for PSA-alpha1-antichymotrypsin with improved performance. European Urology 37(Suppl 2): 121
Piloto, O.A.; Li, Y.; Li, H.; Wang, M.N.; Lu, D.; Wu, Y.; Bassi, R.; Zhang, H.; Ludwig, D.L.; Pytowski, B.; Kussie, P.; Bohlen, P.; Witte, L.; Zhu, Z.; Hicklin, D.J.; Small, D. 2003: Development of monoclonal antibodies capable of inhibiting FLT3 An alternative to small molecule inhibitors for the treatment of leukemias. Blood 102(11): 98a
Pengsuk,C.; Longyant,S.; Rukpratanporn,S.; Chaivisuthangkura,P.; Sridulyakul,P.; Sithigorngul,P. 2010: Development of monoclonal antibodies for simple detection and differentiation of Vibrio mimicus from V cholerae and Vibrio spp by dot blotting. Aquaculture 0: 1 4, 17-24
Zou, Y.; Stastny, P. 2002: Development of monoclonal antibodies specific for native or denatured MICA proteins. Human Immunology 63(Suppl 1): S46
Wilson, S.B.; Ottendorfer, E.W.; Strominger, J.L.; Ellis, T.M.; Atkinson, M.A. 2001: Development of monoclonal antibodies to Valpha24JalphaQ T cells detects alterations in cell frequency in new-onset type 1 diabetes patients. Diabetes 50(Suppl 2): A267
Wong, J.L.; Zheng, Y.T.; Gang, G.; Xu, B.R.; Yang, C.B. 1999: Development of monoclonal antibodies to hemoglobin-acrylamide adducts in rat and human. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S243
Voyles, A.L.; Taylor, B.C. 1999: Development of monoclonal antibodies to quantify immunoglobulin G in Southern Sea Otter. Abstracts of the General Meeting of the American Society for Microbiology 99: 272
Behrmann, J.T.; Stierli, B.; Tonnes, J.; Racca, C.; Nyiri, G.; Mcilhinney, R.A.J.; Somogyi, P.; Streit, P. 1999: Development of monoclonal antibodies to the NMDA receptor subunit NR2A. Society for Neuroscience Abstracts 25(1-2): 1485
Bagge, A.M.; Valtonen, E.T. 1999: Development of monogenean communities on the gills of roach fry (Rutilus rutilus). Parasitology 118: 479-487
Mohsin, N.; Marhuby, H.; Maimani, Y.; Aghanishankar, P.; Al-Hassani, M.; Seth, M.; Daar, A.S. 2003: Development of morbid obesity after transplantation in Laurence Moon Biedle syndrome. Transplantation Proceedings 35(7): 2619
Sommer, B. 2002: Development of mortality in western and eastern Germany since 1991. Zeitschrift für Gerontologie und Geriatrie 35(5): 406-411
Arlotto, T.; Gerber, D.; Terblanche, S.J.; Cooper, D.; Bertschinger, H.J. 2000: Development of morula stage embryos after transvaginal oocyte recovery in the African buffalo, Syncerus caffer. Theriogenology 53(1): 324
Losonczy, A.; Abraham, H.; Czeh, G.; Seress, L. 2000: Development of mossy cells in the rat dentate hilus. European Journal of Neuroscience 12(Suppl 11): 160
Watabe, H.; Sato, N.; Choi, E.; Bloomfield, P.; IIda, H. 2002: Development of motion correction technique for brain PET with optical motion tracking system and listmode acquisition. Journal of Nuclear Medicine 43(5 Suppl): 204P-205P
Kiorpes, L.; Burghardt, N.; Bayer, H.; Tang, C.; Movshon, J.A. 1999: Development of motion sensitivity in macaque monkeys. IOVS Investigative Ophthalmology and Visual Science 40(4): S396
Kubova, Z.; Gayer, D.; Szanyi, J.; Kuba, M.; Kremlacek, J. 2000: Development of motion-specific VEPs in normal and dyslexic children. European Journal of Neuroscience 12(Suppl 11): 128
Bate, M. 1999: Development of motor behaviour. Current Opinion in Neurobiology 9(6): 670-675
Zhang, L.; Li, L.; Liu, F. 2003: Development of mtDNA-transfused cell models of Alzheimers disease and application in Chinese herb study. Journal of Neurochemistry 87(Suppl 1): 104
Okamoto, J.; IIda, M.; Nambu, K.; Okayasu, H.; Fujie, M.G.; Umezu, M.; Iseki, H. 2003: Development of multi-DOF brain retract manipulator for minimally invasive neurosurgery. Lemke, Heinz U , Reprint Author, Vannier, Michael W, Inamura, Kiyonari, Farman, Allan G, Doi, Kunio, Reiber, John H C Computer assisted radiology and surgery: 522-528
Kokalis Burelle, Nancy 2002: Development of multi-component transplant mixes for plant growth-promotion and disease suppression. Nematology 4(2): 153
Phillips, T.D.; Ake, C.L.; Mayura, K.; Huebner, H. 2000: Development of multifunctional clay-based composites for the adsorption of lead and other priority pollutants from contaminated water. Abstracts of Papers American Chemical Society 219(1-2): TOXI 91
Mummert, M.; Takashima, A. 2001: Development of multimeric peptide inhibitors of hyaluronan-mediated leukocyte trafficking. Journal of Investigative Dermatology 117(2): 397
Mafong, D.D.; Lee, G.A.; Yu, S.; Tien, P.; Mauro, T.; Grunfeld, C. 2004: Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy. Aids 18(12): 1742-1744
Dainichi, T.; Tanaka, M.; Tsuruta, N.; Furue, M.; Noda, K. 2003: Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor. Dermatology 207(3): 324-325
Gran, B.; Bielekova, B.; Mcfarland, H.F.; Martin, R. 2000: Development of multiple sclerosis after Hepatitis B vaccination An immunologic case report. Neurology 54(7 Supp 3): A164
Kotob, S.I.; Liebman, M.; Faisal, M. 2000: Development of multiplex PCR assay for the detection of pathogens in environmental samples. Abstracts of the General Meeting of the American Society for Microbiology 100: 562-563
Kim, K.; Boley, M.L.; Van Gelder, R.N. 1999: Development of multiplex PCR assay for viral conjunctivitis. IOVS Investigative Ophthalmology and Visual Science 40(4): S863
Lowe, R.; Byard, J.; Roberts, S.L.L.; Cordingley, H.C. 2003: Development of multiplexed competitive luminex protein assays for toxicity prediction screens. Toxicology Letters (Shannon) 144(Suppl 1): s51
Magata, Y.; Mukai, T.; Tanaka, A.; Kitano, H.; Saji, H. 2001: Development of multipurpose synthetic system. Journal of Labelled Compounds and Radiopharmaceuticals 44(Suppl 1): S1047-S1049
Tudor, K.S.; Payne, K.J.; Yamashita, Y.; Medina, K.L.; Rossi, M.I.D.; Kincade, P.W. 1999: Development of murine B lineage lymphocytes from early hematopoietic precursors. FASEB Journal 13(5 Part 2): A965
Numata, Y.; Ueno, Y.; Tazuma, S.; Komichi, D.; Ishii, H.; Kobuke, T.; Yamaguchi, A.; Ochi, H.; Nishioka, T.; Yasumiba, S.; Sakomoto, M.; Chayama, K. 2001: Development of murine cholangitis based upon ulcerative colitis model induced by dextran sodium sulfate Implication to primary sclerosing cholangitis model. Hepatology 34(4 Pt 2): 373A
Dewald, O.; Ren, G.; Klemm, C.; Winkelmann, K.; Koerting, A.; Taffet, G.; Michael, L.H.; Entman, M.L.; Frangogiannis, N.G. 2004: Development of murine fibrotic cardiomyopathy is dependent on Monocyte Chemoattractant Protein 1. Journal of the American College of Cardiology 43(5 Suppl A): 230A
Hakkinen, A.; Sokka, T.; Kautiainen, H.; Kotaniemi, A.; Hannonen, P. 2003: Development of muscle strenght, bone mineral density, physical function, joint damage and clinical disease activity in patients with early rheumatoid arthritis Impact of physical training A 5-year prospective Study. Calcified Tissue International 72(4): 393-394
Singleton, S.F.; Berger, M.D.Jr; Simonette, R.A.; Lee, A.M. 2000: Development of mutant RecA proteins with unique fluorescent residues. Abstracts of Papers American Chemical Society 219(1-2): BIOL 164
Weegink, C.J.; Molenaar, D.S.; Chamuleau, R.A.; Reesink, H.W. 2000: Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin A case report. Hepatology 32(4 Pt 2): 565A
Nishikawa, T.; Masuda, A.; Sakomura, Y.; Tanaka, K.; Uto, K.; Koyanagi, R.; Kasanuki, H.; Kobayashi, M. 2003: Development of myocardial damage in the chronic stage of rat myocarditis. FASEB Journal 17(4-5): Abstract 216
Dewald, O.; Frangogiannis, N.G.; Zoerlein, M.; Duerr, D.; Taffet, G.; Michael, L.H.; Entman, M.L. 2002: Development of myocardial hibernation in mice is associated with chemokine induction and macrophage recruitment. European Heart Journal 23(Abstract Suppl): 16
Emura, M.; Ochiai, A.; Horino, M.; Arndt, W.; Kamino, K.; Hirohashi, S. 2000: Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cellular and Developmental Biology. Animal 36(2): 77-80
Ishikawa, S.; Tsuchiya, K.; Otsuka, N.; Namba, T.; Ukai, K. 2000: Development of myopia due to environmental problems A possible interaction of anti-cholinesterase compounds examined by accommodative adaptation. Franzen, Ove , Richter, Hans , Stark, Lawrence Accommodation and vergence mechanisms in the visual systems 327-340
Mccabe, V.J.; Spibey, N. 2002: Development of myxoma recombinant viruses for vaccination against feline calicivirus. Research in Veterinary Science 72(Suppl A): 24
Wiest, O.; Picot, D.; Wang, D.F.; Griffith, B.D.; Helquist, P.; Miller, M.J.; Tenniswood, M. 2003: Development of naaladase inhibitors Toward the detection and treatment of prostate cancer. Abstracts of Papers American Chemical Society 225(1-2): MEDI 101
Grassian, V.H.; Larsen, S.C.; Alwy, H.; Li, G. 2003: Development of nanocrystalline zeolite materials as environmental catalysts. Abstracts of Papers American Chemical Society 225(1-2): IEC 86
Botta, R.S.; Ballas, Z.K.; Hussain, I. 2002: Development of nasal polyposis in immunosuppressed patients. Journal of Allergy and Clinical Immunology 109(1 Suppl): S319
Blackburn, H.D. 2004: Development of national animal genetic resource programs. Reproduction Fertility and Development 16(1-2): 27-32
Radcliff, F.J.; Labigne, A.; Ferrero, R.L. 1999: Development of natural immunity in mice exposed to a sub-infectious dose of the mouse-adapted H pylori ss1 strain. Immunology Letters 69(1): 48
Mickelbart, M.V.; Joly, R.J.; Rhodes, D.; Goldsbrough, P.B.; Ejeta, G. 1999: Development of near-isogenic lines of sorghum accmulating different concentrations of glycinebetaine. Plant Biology (Rockville) : 120
Natarajan, A.R.; Ebert, S.N. 2002: Development of neonatal cardiomyocyte beating activity Role of intrinsic cardiac catecholamines. Pediatric Research 51(4 Part 2): 462A
Lubinski, J. 2004: Development of network of cancer family syndrome registries in Eastern Europe. EJC Suppls 2(3): 184
Palsson, B.O.; Price, N.D.; Papin, J.A. 2003: Development of network-based pathway definitions: the need to analyze real metabolic networks. Trends in Biotechnology 21(5): 195-198
Peyronnet, J.; Maliere, S.; Roux, J.C.; Perrin, D.; Lagercrantz, H.; Pequignot, J.M.; Dalmaz, Y. 2003: Development of neural chemoafferent pathway and respiration is altered following prenatal nicotine exposure in rats. Pediatric Research 53(4 Part 2): 424A
Yamakado, M.; Akita, M.; Yokoyama, A. 2000: Development of neural connections in the topographic organization of vibrissal rudiments Conditioning in whole-embryo culture. Neuroscience Research Suppl (24): S135
Nagono, T.; Iwakura, Y.; Ushiki, T.; Nawa, H. 1999: Development of neurites, dendritic filopodia, and synaptic spines in hippocampal low-density culture. Uyemura, K, Kawamura, K, Yazaki, T Keio University Symposia for Life Science and Medicine; Neural development 386-393
Prisinzano, T.; Rice, K.C.; Baumann, M.H.; Rothman, R.B. 2004: Development of neurochemical normalization therapeutics for stimulant abuse Focus on the dopamine uptake inhibitor, GBR12909. Current Medicinal Chemistry - Central Nervous System Agents 4(1): 47-59
Eissele, L.; Gohlmann, D.; Arnold, R.; Beato, H.; Slater, E.P. 1999: Development of neuroendocrine B-cell tumors in transgenic mice An animal model for investigation of carcinogenesis B-cells. Gastroenterology 116(4 Part 2): A1120
Lee, S.H.; Sheng, M. 2000: Development of neuron-neuron synapses. Current Opinion in Neurobiology 10(1): 125-131
Jefferis, G.S.X.E.; Marin, E.C.; Watts, R.J.; Luo, L. 2002: Development of neuronal connectivity in Drosophila antennal lobes and mushroom bodies. Current Opinion in Neurobiology 12(1): 80-86
Kreischer, S.; Mueller, M.C. 2001: Development of neuronal structures in stolons of Autolytus prolifer. Zoology (Jena) 103(Suppl 3): 58
Watanabe, Y.miko; Cui, Yilong; Satoh, Takumi; Kataoka, Yosky; Nakatsuka, Daisaku; Takamatsu, Hiroyuki; Tsukada, Hideo; Suzuki, Masaaki; Watanabe, Yasuyoshi 2000: Development of neuroprotective drug active through a novel prostacyclin receptor. Neuroscience Research Suppl (24): S10
Willoughby, T.E.; Hall, P.D.; Frankel, A.E. 2000: Development of neutralizing antibodies to DT-GM during a phase I study in patients with relapsed/refractory acute myeloid leukemia. Pharmacotherapy 20(10): 1256
Arnon, S.; Maslanka, S.; Schechter, R.; Hatheway, C. 2002: Development of neutralizing serum antibodies to botulinum toxin in patients with infant botulism. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 2): R11
Piccirilli, A.; Legrand, J.; Msika, P. 2001: Development of new 5-alpha-reductase inhibitors. Journal of Investigative Dermatology 117(2): 548
Okarvi, S.M. 2002: Development of new 99mTc-MAG3-like agents as potential renal radiopharmaceuticals. Journal of Nuclear Medicine 43(5 Suppl): 375P-376P
Kawagoe, K.; Morikawa, T.; Izutsu, H.; Culligan, T.; Senese, A.; Svejkar, M. 1999: Development of new Chlamydia pneumoniae IgG and IgA ELISAs. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S494
Greene, D.W. 2000: Development of new PGRs from a University perspective. HortScience 35(3): 518
Hardy, E. 2003: Development of new albumin-free formulations of interferon alpha 2b for clinical purposes. Tulunay, F C, Orme, M European collaboration: Towards drug development and rational drug therapy: 87
Linetsky, M.D.; Legrand, R.D.; Ortwerth, B.J. 2000: Development of new approaches for determination of glycation-mediated crosslinks in the human lens. IOVS Investigative Ophthalmology and Visual Science 41(4): S587
Sakai, T.; Sowa, Y. 2002: Development of new cancer chemotherapy or chemoprevention using regulation of transcription. Japanese Journal of Pharmacology 88(Suppl 1): 39P
Smejkal, G.B. 2003: Development of new colloidal stains Narrowing the gap between coomassie and silver staining sensitivity. Molecular and Cellular Proteomics 2(9): 851
Sugioka, K.; Hibino, T.; Fukuda, M.; Shimomura, Y.; Watanabe, M.; Kato, H.; Yasuda, A.; Ando, I. 2001: Development of new designed keratoprosthesis. IOVS Investigative Ophthalmology and Visual Science 42(4): S270
Elisabettini, P.; Crnogatic, M.; Divino, J.; Recordi, L.; Van Breedam, B.; Wilmet, I. 2002: Development of new dialysate solutions containing bicarbonate. Blood Purification 20(3): 310
Ziche, M.; Donnini, S.; Morbidelli, L. 2004: Development of new drugs in angiogenesis. Current Drug Targets 5(5): 485-493
Kim, H.J.; Eom, T.J.; Jo, B.M. 2002: Development of new enzymes and their applications to the modification of pulp fibers and deinking of mow. Abstracts of Papers American Chemical Society 223(1-2): CELL 72
Zhang, W.; Luo, Z.; Nagashima, T.; Chen, C.H.T.; Irwin, J.; Curran, D.P. 2002: Development of new fluorous compounds for high throughput organic synthesis. Abstracts of Papers American Chemical Society 224(1-2): ORGN 135
Kumazawa, S.; Ito, A.; Saishoji, T.; Chuman, H. 2000: Development of new fungicides, ipconazole and metconazole. Journal of Pesticide Science 25(3): 321-331
Lee, D.H.; Ji, Y.H.; Lee, D.H.; Yoo, S.Y.; Cho, C.K.; Yu, H.J.; Kim, M.S. 2000: Development of new head fixation frame and frame mounting system for fractionated stereotactic radiotherapy of brain tumors. International Journal of Radiation Oncology Biology Physics 48(3 Suppl): 346
Nitz, M.; Franz, K.J.; Imperiali, B. 2002: Development of new high affinity lanthanide binding tags based upon the 20 commonly occurring amino acids. Abstracts of Papers American Chemical Society 224(1-2): ORGN 380
Yahata, Y.; Murakami, S.; Hashimoto, K. 2000: Development of new histamine measurement system use of confocal laser microscope and human dermal microvascular endothelial cells. Journal of Dermatological Science 23(3): 204
Hubler, T.L.; Bryan, S.A.; Carver, C.T.; Thornton, M.E.; Hammack, K.L.; Seliskar, C.J.; Heineman, W.R. 2001: Development of new ion-exchange polymers for technetium sensors applicable to the vadose zone. Abstracts of Papers American Chemical Society 222(1-2): NUCL80
Li, K.; Xu, F. 2000: Development of new laccase mediators pulp bleaching. Abstracts of Papers American Chemical Society 219(1-2): CELL 152
Zhang, M.X.; Eaton, P.E. 2001: Development of new magnesium bases for a-, b-deprotonation of cyclopropane derivatives and its application to the synthesis of drug relevant compounds. Abstracts of Papers American Chemical Society 222(1-2): ORGN42
Gero, A.M.; Weis, A.L. 2001: Development of new malaria chemotherapy by utilization of parasite-induced transport. Rosenthal, Philip J , Reprint Author Antimalarial chemotherapy: Mechanisms of action, resistance, and new directions in drug discovery: 367-384
Yunuskhodzhaev, A.N.; Shaislamov, B.S. 2003: Development of new medications and medication quality control Problems and possible solutions. Uzbekiston Tibbiet Zhurnali 1: 61-62
Shoislamov, B.S.; Aliev, H.U. 2001: Development of new medicines and realization of a national program. Uzbekiston Tibbiet Zhurnali (5-6): 26-27
Welty, G.; Klinge, U.; Stumpf, M.; Klosterhalfen, B.; Schumpelick, V. 2000: Development of new mesh materials for hernia repair and clinical outcome of different polypropylene meshes. European Surgical Research 32(Suppl 1): 3-4
Gillespie, J.W.; Best, C.; Cole, K.; Hewitt, S.; Ahram, M.; Gathright, Y.; Epstein, J.; Hamilton, S.; Gannot, G.; Chuaqui, R.; Herring, J.; Bichsel, V.; Calvert, V.; Petricoin, E.; Linehan, W.M.; Duray, P.; Bova, G.S.; Emmert Buck, M. 2001: Development of new methods for processing clinical samples for molecular profiling studies. Proceedings of the American Association for Cancer Research 42: 492
Malik, N.; Peeples, C.J.; Dicesare, J.C. 2002: Development of new methods for the resolution of a-L-difluoromethyl lysine. Abstracts of Papers American Chemical Society 223(1-2): CHED 712
Ley, S.V. 2003: Development of new methods suitable for natural product synthesis. Abstracts of Papers American Chemical Society 225(1-2): ORGN 197
Yamamoto, M.; Otani, M.; Otsuki, M. 2003: Development of new model of chronic pancreatitis in rats. Pancreas 27(4): 418-419
Corr, L.T.; Mukherjee, A.; Jim, S.; Sponheimer, M.; Hobson, K.A.; Evershed, R.P. 2003: Development of new models for dietary reconstruction based on bulk and compound specific d13C analysis of diet and consumer tissues. Abstracts of Papers American Chemical Society 225(1-2): GEOC 135
Zhang, Z.M.; Ng, Y.K.; Bayani, J.; Marrano, P.; Zielenska, M.; Squire, J. 1999: Development of new molecular genetic markers of outcome in pediatric Ewing group tumour. American Journal of Human Genetics 65(4): A332
Huygen,K.; Bull,T.; Collins,D.M. 2010: Development of new paratuberculosis vaccines. Paratuberculosis: Organism, Disease, Control: 3-368
Ito, M.; Tomioka, M.; Inoue, H.; Kumagai, N. 2002: Development of new pressure ulcer model in mice and its application. Japanese Journal of Pharmacology 88(Suppl 1): 116P
Macmillan, D.W.C.; Austin, J.; Borths, C.J.; Brown, S.; Dong, V.M.; Jen, W.S.; Kwan, B.; Northrup, A.; Paras, N.A.; Park, J.; Seo, J.; Wiener, J.S.; Wilson, R.M.; Yoon, T.P. 2001: Development of new reaction methods of broad utility to enantioselective catalysis and complex target synthesis. Abstracts of Papers American Chemical Society 222(1-2): ORGN31
Zaied, K.A.; Abou Zeid, A.M. 2001: Development of new recombinant yeast Saccharomyces cerevisiae strains. Egyptian Journal of Microbiology 34(4): 693-714
Terai, S.; Yamamoto, N.; Sakaida, I.; Sakaguchi, E.; Miyamoto, K.; Okita, K. 2001: Development of new regenerative model Transplanted GFP positive bone marrow cell migrated into damaged area and differentiated into hepatocyte. Hepatology 34(4 Pt 2): 235A
Bernacki, R.J.; Ojima, I.; Pera, P.; Veith, J.; Olden, A.; Mehta, M.; Bounaud, P.Y.; Bombardelli, E. 1999: Development of new semisynthetic taxanes and taxane-based drug resistance reversal agents designed to overcome MDR1-associated multidrug resistance. Proceedings of the American Association for Cancer Research 40: 284-285
Fery, R.L.; Thies, J.A.; Dukes, P.D.Sr 1999: Development of new southernpea cultivars An update on the USDA effort. HortScience 34(5): 838
Sawa, Y.; Fukushima, N.; Nishimura, M.; Sakaguchi, T.; Ohtake, S.; Matsuda, H. 2000: Development of new techniques using genetic and tissue engineering for the treatment of severe heart failure. Transplantation Proceedings 32(2): 242-244
Saxena, P.K.; Krishnaraj, S.; Murch, S.J. 2000: Development of new technologies for plant-based medicines. Abstracts of Papers American Chemical Society 219(1-2): AGFD 73
Venuti, A.; Marcante, M.L.isa 2003: Development of new therapeutic strategies against cervix cancer. International Journal of Molecular Medicine 12(Suppl 1): S82
Gross, R.A.; Fuhrman, J.; Kaplan, D.L. 2000: Development of new therapeutics from microbial biosurfactants and biomolecules. Abstracts of Papers American Chemical Society 219(1-2): CARB 80
Silo Suh, L.A.; Suh, S.J.; Ohman, D.E. 2000: Development of new tools to facilitate genetic manipulations in Pseudomonas aeruginosa. Abstracts of the General Meeting of the American Society for Microbiology 100: 260
Masliah, E. 2001: Development of new treatments for Parkinsons disease in transgenic animal models. Neurotoxicology (Little Rock) 22(6): 871
Dell'Osso, L.F. 2002: Development of new treatments for congenital nystagmus. Annals of the new York Academy of Sciences 956: 361-379
Campiglia, P.; Grieco, P.; Carotenuto, A.; Zampelli, E.; Patacchini, R.; Maggi, C.A.; Rovero, P.; Novellino, E. 2003: Development of new urotensin-II receptor ligands. Biopolymers 71(3): 374
Acs, K.; Nyilasi, I.; Papp, T.; Vagvolgyi, C. 2003: Development of new vector systems for transformation of zygomycetes. FEMS Congress of European Microbiologists Abstract Book 1: 452
Steierhoffer, F.; Recker, K.; Wohlrab, J. 2004: Development of new vehicle systems for cutaneous gene therapy. Archives of Dermatological Research 295(8-9): 360
Miyamoto, M.; Morimoto, Y.; Nozawa, Y.; Inoue, K.; Tamori, A.; Kaetsu, I. 2000: Development of newly local chemotherapy for solid cancer by implantable drug delivery system with thermo-responsive solgel transition polymer. European Surgical Research 32(Suppl 1): 15
Kasuya, H.; Kawashima, A.; Sasahara, A.; Onda, H.; Hori, T. 2001: Development of nicardipine prolonged-release implants for preventing vasospasm. Acta Neurochirurgica. Supplement 77: 217-220
Mitchell, G.; Sauter, E.; Sibley, P.A.; Wilson, P.; Eeles, R.A. 1999: Development of nipple fluid aspiration as a screening tool for breast cancer in genetically predisposed women Menstrual cycle fluctuation of putative biomarkers of breast cancer risk. Journal of Medical Genetics 36(Suppl 1): S74
Meinhardt, G.; Sechtem, U. 2000: Development of nitrate tolerance. Deutsche Medizinische Wochenschrift 125(Suppl 1): S7
Rosecrance, R.C.; Weinbaum, S.A.; Brown, P.H. 2001: Development of nitrogen and potassium fertilizer recommendation models to improve N and K use efficiency and to alleviate pollution from pistachio orchards. HortScience 36(3): 464
Girault, J-Antoine.; Peles, E. 2002: Development of nodes of Ranvier. Current Opinion in Neurobiology 12(5): 476-485
Tartour, E. 2000: Development of non live vectors as tools for cancer vaccines. Immunology Letters 73(2-3): 97
Stemberger, M.; Stemberger, A.; Grippner Steppert, C.; Sutor, A. 2001: Development of non-activated whole blood thromboelastography as a reliable bedside test Investigations concerning the influence of storage on clotting time. Annals of Hematology 80(Suppl 1): A62
Takahashi, T. 2003: Development of non-halogen chemical processes. Nippon Nogeikagaku Kaishi 77(1): 26-29
Gunaratne, G.H.; Mohanty, K.K.; Wimalawansa, S.J. 2001: Development of non-invasive diagnostics for osteoporosis A model based approach. Journal of Bone and Mineral Research 16(Suppl 1): S245
Lee, J.W.; Lee, H.N.; Hahm, Y.T. 2000: Development of non-protoplast transformation system in Aspergillus oryzae. Mycobiology 28(4): 221
Gysin, R.; Strong, D.; Wergedal, J.; Miyakoshi, N.; Kodama, Y.; Qin, X.; Mohan, S.; Baylink, D. 1999: Development of nonviral basic FGF expression plasmids for ex vivo gene therapy of bone. Journal of Bone and Mineral Research 14(Suppl 1): S460
Wakayama, T.; Yanagimachi, R. 2003: Development of normal offspring from oocytes injected with freeze-dried spermatozoa. Official Gazette of the United States Patent and Trademark Office Patents 1276(1)
Choi, S.W.; Elmaleh, D.R.; Fischman, A.J. 1999: Development of novel DAT radioligands Design, synthesis and in vitro evaluation of acyclic amine-amide analogs of GBR 12909 and 12935. Journal of Nuclear Medicine 40(5 Suppl): 305P
PanLei; XiaQiuJu; QuanZhiWu; LiuHongGao; KeWeiDong; DingYi 2010: Development of novel EST-SSRs from sacred lotus and their utilization for the genetic diversity analysis of N nucifera. Journal of Heredity 1(1): 71-82
Ainscough, S.L.; Upton, Z.; Harkin, D. 2004: Development of novel IGF complexes for serum-free propagation of human limbal epithelial cells for therapeutic applications. Growth Hormone and IGF Research 14(2): 114
Zhuang, Y.; Smith, C.D. 2002: Development of novel N-substituted azabicyclooctane compounds as selective P-glycoprotein inhibitors. Abstracts of Papers American Chemical Society 224(1-2): MEDI 170
Tamai, K.; Morishita, R.; Nakamura, H.; Chiba, Y.; Kaneda, Y.; Hanada, K. 2003: Development of novel NFkappaB decoy oligonucleotide ointment and the first successful clinical trial for severe atopic dermatitis patients. Journal of Investigative Dermatology 121(1): 1188
Naugle, J.L.; Wang, Y. 2002: Development of novel Src Tyrosine kinase inhibitors for the treatment of osteoporosis. Abstracts of Papers American Chemical Society 224(1-2): MEDI 369
M.L.ughlin, B.M.; Dooley, C.M.; Devocelle, M.; Nolan, K.B.; Fitzgerald, D.J.; Sharkey, C.T. 2002: Development of novel acetylating agents as selective prostaglandin H2 synthase -1 inhibitors. Circulation 106(19): II149
Matsuda, K.; Kawaura, H.; Uchiyama, M.; Onoue, S.; Kashimoto, K.; Kikuyama, S.; Arimura, A. 2002: Development of novel and sensitive enzyme-immunoassay for PACAP Comparison of brain PACAP concentrations among some vertebrate species. Zoological Science 19(12): 1484
Wainberg, M.A.; Detorio, M.; Moliveira; Diallo, K. 2001: Development of novel anti-HIV vaginal microbicides. Antiviral Research 51(1): 8-9
Pelletier, J.; Gros, P.; Dubow, M. 2004: Development of novel anti-microbial agents based on bacteriophage genomics. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)
Dougall, B. 2003: Development of novel anti-resorptive therapies targeting the RANKL-RANK signaling pathway. European Cytokine Network 14(Suppl 3): 8
Lacey, D.L. 2003: Development of novel anti-resorptive therapies targeting the RANKL-RANK signaling pathway From functional genomics to bedside. Calcified Tissue International 72(4): 316
Kim, J.M.; Ellman, J.A. 1999: Development of novel antimalarial agents targeting heme polymerization. Abstracts of Papers American Chemical Society 218(1-2): MEDI 291
Lohner, K. 2001: Development of novel antimicrobial agents Emerging strategies. Lohner, Karl Development of novel antimicrobial agents: Emerging strategies i-xi, 1-284
Tallman, J.F. 2000: Development of novel antipsychotic drugs. Brain Research. Brain Research Reviews 31(2-3): 385-390
Kumar, A.P.; Garcia, G.E.; Rajnarayanan, R.; Alworth, W.L.; Slaga, T.J. 2001: Development of novel apoptotic inducers for prostate cancer therapy. Proceedings of the American Association for Cancer Research 42: 448
Bilello, J.; Belay, S.; Weislow, O.S. 2001: Development of novel approaches to the evaluation of virucidal agents Separation of treated virions from test compounds. AIDS 15(Suppl 1): S39
Setsukinai, K.I.; Urano, Y.; Majima, H.J.; Hirose, K.; Nagano, T. 2001: Development of novel autoxidation-resistant fluorescence probes for highly reactive oxygen species with high sensitivity and selectivity. Free Radical Biology and Medicine 31(10): S125
Duan, J.J.W.; Chen, L.; Decicco, C.P.; Cherney, R.J.; Wasserman, Z.R.; Kennedy, K.E.; Meyer, D.T.; Wang, L.; Voss, M.E.; Hardman, K.D.; Arner, E.C.; Covington, M.B.; Liu, R.R. 1999: Development of novel benzothiadiazepine-derived hydroxamic acids as metalloproteinase inhibitors. Abstracts of Papers American Chemical Society 218(1-2): MEDI 88
Cho, C.M.e Hie; Mulchandani, A.; Chen, W. 2002: Development of novel biocatalysts for improved degradation of chlorpyrifos. Abstracts of Papers American Chemical Society 224(1-2): BIOT 155
Uranchimeg, B.; Rapisarda, A.; Shoemaker, R.H.; Scudiero, D.A.; Selby, M.H.; Sausville, E.A.; Melillo, G. 2001: Development of novel cancer therapeutics targeting hypoxia inducible factor 1. Proceedings of the American Association for Cancer Research 42: 830
Greco, O.; Marples, B.; Joiner, M.C.; Scott, S.D. 2003: Development of novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Cancer Gene Therapy 10(Suppl 1): S25
Sasson, S.; Gruzman, A.; Alpert, E.; Katzhendler, Y.; Cerasi, E. 2003: Development of novel compounds that stimulate glucose transport in a non-insulin dependent manner. Diabetes and Metabolism 29(Hors serie 2): 4S267
Boyce, B.F.; Xing, L.; Wang, Y.; Sundaramoorthi, R.; Keenan, T.; Yamashital, T.; Shakespeare, W.; Dalgarno, D.; Iuliucci, J.; Sawyer, T. 2003: Development of novel dual-action Src kinase inhibitors preventing bone resorption and stimulating bone formation in vitro and in vivo. Calcified Tissue International 72(4): 331
Mcclain, A.R.; Lange, C. 2003: Development of novel fibrous structures for sorption of environmental contaminants. Abstracts of Papers American Chemical Society 226(1-2): ENVR 48
Urano, Y. 2004: Development of novel fluorescence probes based on rational design principles. Journal of Pharmacological Sciences 94(Suppl 1): 17P
Setsukinai, K.I.; Urano, Y.; Kakinuma, K.; Majima, H.; Nagano, T. 2003: Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species, and their application to living neutrophils. Free Radical Biology and Medicine 35(Suppl 1): S149
Gaits, F.; Nalbant, P.; Toutchkine, A.; Hahn, K.M. 2003: Development of novel fluorescent biosensors reporting activation in vivo. FASEB Journal 17(4-5): Abstract 463
Harbour, M.; Bucher, K.; Vadlamudi, A.; Lee, R.; Schoenberg, M.; Sidransky, D.; Larder, B.; Medghalchi, S. 2001: Development of novel high throughput microsatellite technology for detection of bladder cancer. European Journal of Cancer 37(Suppl 6): S117-S118
Fahey, J.W. 2003: Development of novel highly chemoprotectant crucifer germplasm. Official Gazette of the United States Patent and Trademark Office Patents 1267(3)
Chiosis, G.; Rosen, N.; Lucas, B. 2002: Development of novel hsp90 inhibitors as cancer therapeutics. Abstracts of Papers American Chemical Society 224(1-2): MEDI 228
Johnson, R.J.; Maves, S.A.; Kastrup, L. 2004: Development of novel inhibitors of complement. FASEB Journal 18(4-5): Abstract 777
Jeong, Y.; Swenberg, J.A. 2003: Development of novel internal standard DNA for DNA adduct assays. Toxicological Sciences 72(S-1): 249
Srivastava, S.C.; Meinken, G.E.; Awasthi, V.; Springer, K.; Mausner, L.F.; Kolsky, K.L.; Freimuth, P. 2002: Development of novel ligands based on adenoviral protein scaffolds for molecular imaging. Journal of Nuclear Medicine 43(5 Suppl): 376P
Glick, S.D.; Maisonneuve, I.M. 2000: Development of novel medications for drug addiction. the legacy of an African shrub. Annals of the new York Academy of Sciences 909: 88-103
D'ambra, A.J.; Arnold, F.; Clark, B.A.; Coffman, R.K.; Faust, S.K.; Jacoby, J.S.; Kruk, J.R.; Pekala, D.J.; Soika, M. 2001: Development of novel meningococcal conjugates for a tetravalent infant vaccine Process and analytical perspectives. Abstracts of Papers American Chemical Society 222(1-2): CARB52
Yoon, S.S.; Choi, H.Y.; Ahn, K.S.; Kim, J.; Park, K.; Lee, H. 2001: Development of novel method for isolating metastatic genes using an in vivo model The investigation of their expression patterns in metastatic human renal cell carcinoma. Proceedings of the American Association for Cancer Research 42: 795
Tainaka, K.; Okamoto, A.; Saito, I. 2002: Development of novel modified nucleobases as a fluorescence probe for detection of single nucleotide polymorphisms. Abstracts of Papers American Chemical Society 224(1-2): MEDI 158
Lewis, G.K.; Shata, M.T.; Fouts, T.R.; Devico, A.L.; Bagley, K.; Abdelwahab, S.; Kamin Lewis, R.; Reitz, M.; Hone, D.M. 2000: Development of novel mucosal vaccines against HIV-1. Journal of Human Virology 3(5): 259
Mortensen, D.S.; Katzenellenbogen, J.A. 2000: Development of novel nonsteroidal estrogen receptor-alpha selective ligands. Abstracts of Papers American Chemical Society 219(1-2): MEDI 328
Debata, C.; Penn, D. 2001: Development of novel nucleic acid probes for liver and muscle isoforms of porcine carnitine palmitoyltransferase-1. FASEB Journal 15(5): A1186
Rando; Nguyen-Ba 2000: Development of novel nucleoside analogues for use against drug resistant strains of HIV-1. Drug Discovery Today 5(10): 465-476
Liu, G.; Fan, Y.; Zhao, D.; Zhao, Z.G.; Lam, K.S. 2000: Development of novel peptide antibiotics for vancomycin resistant infection using the one-bead, one-compound combinatorial library method. Fields, Gregg B Author, Tam, James P Author, Barany, George Author Peptides for the new millennium 736-737
Miller, D.K.; Zheng, G.; Norrholm, S.D.; Grinevich, V.P.; Crooks, P.A.; Dwoskin, L.P. 2003: Development of novel pharmacotherapies for methamphetamine abuse cis-lobelane, an analog of lobeline. FASEB Journal 17(4-5): Abstract 140
Mian, B.M.; Agartan, C.; Nazeer, T.; Levin, R.M. 2004: Development of novel rabbit bladder cancer model for endoscopic evaluation of intravesical and intralesional therapies A preliminary report. Journal of Urology 171(4 Suppl): 188
Zhang, Z.; Machac, J.; Albanis, E.; Lipszyc, H.; Beljaars, L.; Poelstra, K.; Friedman, S.L. 2001: Development of novel radiotracer for liver fibrosis evalution. Journal of Nuclear Medicine 42(5 Suppl): 71P
Mizokami, M.M.; Hu, P.; Khawli, L.A.; Epstein, A.L. 1999: Development of novel reagents for the targeting of solid tumors. Proceedings of the American Association for Cancer Research 40: 643-644
Setsukinai, K.I.; Urano, Y.; Kakinuma, K.; Majima, H.; Nagano, T. 2002: Development of novel reliable fluorescence probes to detect reactive oxygen species which can distinguish specific species. Free Radical Biology and Medicine 33(Suppl 2): S425
Gusterson, B.A.; Cui, W.; Clark, A.John. 2003: Development of novel selective cell ablation in the mammary gland and brain to study cell-cell interactions and chemoprevention. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 163: 31-45; Discussion 264-6
Frenette, R. 2003: Development of novel series of potent phosphodiesterase-4 inhibitors SAR studies on substituted 4- pyridine-n-oxides. Abstracts of Papers American Chemical Society 226(1-2): ORGN 472
Koshiishi, I.; Utsumi, H. 2002: Development of novel spin probe for evaluation of nitric oxide generation by in vivo EPR/spin probe method. Nitric Oxide 6(4): 418
Buchete, N.-V.; Straub, J.E.; Thirumalai, D. 2004: Development of novel statistical potentials for protein fold recognition. Current Opinion in Structural Biology 14(2): 225-232
Shalaby, W.S.W.; Yeh, H.; Woo, E.; Hendren, S.; Corbett, J.T.; Gray, H.; June, C.H.; Shalaby, S.W. 2003: Development of novel substrates for tumor immunotherapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 91(1-2): 209-224
Lark, M.W.; Blake, S.M. 2004: Development of novel therapeutics to treat joint diseases - what can be learned from other disease areas? Editorial overview. Current Opinion in Pharmacology 4(3): 273-275
Roring, S.; Scott, A.; Skuce, R.A.; Neill, S.D. 2001: Development of novel variable number tandem repeat typing of Mycobacterium bovis. Research in Veterinary Science 70(Suppl A): 48
Pennington, O.J.; Davis, T.; Bennik, M.; Mauchline, M.; Peck, M.; Minton, N.P. 2003: Development of novel vectors for use in C sporogenes and C botulinum, based on the C botulinum plasmid PBP1. Anaerobe 9(4): 214-215
Cho, S.R.; Rho, G.J.; Lee, H.J.; Choe, S.Y. 2003: Development of nuclear transfer bovine embryos derived from fetal fibroblasts. Theriogenology 59(1): 243
Knott, J.G.; Kasinathan, P.; Robl, J.M. 2000: Development of nuclear transfer embryos from fetal and adult bovine fibroblasts. Theriogenology 53(1): 227
Du, Z.T.; Verma, P.J.; Crocker, L.A.; Faast, R.; Lyons, I.G.; Nottle, M.B. 1999: Development of nuclear transfer embryos using porcine fetal fibroblasts. Theriogenology 51(1): 201
Yang, B.C.; Im, G.S.; Seong, H.H.; Im, S.K.; Sakiko, M.; Park, S.B.; Chang, W.K.; Im, K.S.; Lee, C.K. 2003: Development of nuclear-transfer embryos using vitrified-warmed in vitro-matured bovine oocytes. Theriogenology 59(1): 317
XueLiGang; LiuJinHua; WangQuanKai(etal) 2010: Development of nucleic acid probe method for determination of Staphylococcus aureus. Chinese Journal Of Biologicals: 1, 91-94
Kassis,N.; Drake,S.R.; Beamer,S.K.; Matak,K.E.; Jaczynski,J. 2010: Development of nutraceutical egg products with omega-3-rich oils. Lwt: 5, 777-783
Jicha, T.M.; Detenbeck, N.E.; Moffett, M.F.; Elonen, C.M.; Anderson, L.E. 2001: Development of nutrient exposure and biological response indicators for Lake Michigan coastal wetlands. IAGLR Conference Program and Abstracts 44: 60
Fielder, A.R.; Jauregui Renaud, K.; Shallo Hoffmann, J. 1999: Development of nystagmus in albinism. IOVS Investigative Ophthalmology and Visual Science 40(4): S962
Pollok, B.; Prior, H.; Güntürkün, O. 2000: Development of object permanence in food-storing magpies (Pica pica). Journal of Comparative Psychology 114(2): 148-157
Fernandez, F.; Jaramillo, A.; Liu, D.; Chen, C.; Mohanakumar, T. 2003: Development of obliterative airway disease after heterotopic tracheal transplantation is abrogated in tumor necrosis factor deficiency in either donor or recipient. Human Immunology 64(Suppl 1): S46
Ndegwa, P.N.; Mihok, S. 1999: Development of odour-baited traps for Glossina swynnertoni. Bulletin of Entomological Research 89(3): 255-261
Karakurt, Y.; Huber, D.J.; Sherman, W.B. 1999: Development of off-flavor in melting flesh and nonmelting flesh peach genotypes. HortScience 34(3): 504
Kumar, S.; Hirota, B.K.; Hernandez, S.; Libel, D.; Parada, L.; De Vellis, J.P. 2001: Development of oligodendroglial cells in NT-3 knockout mice brain. Journal of Neurochemistry 78(Suppl 1): 29
Jigami, Y. 2003: Development of oligosaccharide synthesis system based on yeast cell surface protein display technology and analysis of cell wall synthesizing components by an in vivo reporter system to detect the localization of cell surface mannoproteins. Nippon Nogeikagaku Kaishi 77(10): 994-997
Jayson, G.C.; Pye, D.; Gallagher, J.T. 1999: Development of oligosaccharides as anti-angiogenic agents. Proceedings of the American Association for Cancer Research 40: 19
Zopf, D.A. 2000: Development of oligosaccharides as anti-infective drugs. Abstracts of Papers American Chemical Society 219(1-2): CARB 59
Tan, B.H.; See, E'ein; Lim, E.; Yap, E.P. Huat 2002: Development of one-step RT-PCR for the detection of an RNA virus, dengue, on the capillary real-time thermocycler. Reischl, Udo , Reprint Author, Wittwer, Carl, Cockerill, Franklin Rapid cycle real-time PCR: Methods and applications: Microbiology and food analysis: 241-248
Chun, Y-Hyun.; Jeong, Y-Ju.; Park, S-Ik.; Hosmillo, M.; Shin, D-Jun.; Kwon, H-Jun.; Kang, S-Young.; Woo, S-Kyu.; Kang, M-Il.; Cho, K-Oh. 2010: Development of one-step real-time reverse transcription polymerase chain reaction assays for rapid detection of porcine group C rotaviruses. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 22(1): 74-77
Powers, A.M.; Foy, B.; Brault, A.C.; Higgs, S.; Weaver, S.C.; Olson, K.; Miller, B.R. 2003: Development of onyong nyong virus vectors for infection and expression studies in the malaria-transmitting mosquito, Anopheles gambiae. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 436
Okayama, T.; Takeuchi, Y.; Matsumoto, Y.; Ogawa, T.; Takeuchi, T.; Hagiwara, M.; Achiwa, K.; Sakurada, S.; Morikawa, T. 2003: Development of optically active fluorine-containing amino acids as the source of new pharmaceuticals Establishment of large-scale process and application to lead development of peptide analgesic. Abstracts of Papers American Chemical Society 226(1-2): FLUO 3
Qui, W.; Zheng, J. 2003: Development of oral and maxillofacial oncology in China. Chinese Medical Journal 116(10): 1567-1573
Nakase, H.; Okazaki, K.; Chiba, T. 1999: Development of oral drug delivery system targeting immune responsive cells in a colitis model New therapeutic strategy. Gastroenterology 116(4 Part 2): A782
Otvos, L.J.; Weiner, D.J.; Johnson, D.E.; Cudic, M. 2003: Development of orally active antibacterial peptide derivatives that kill resistant urinary and respiratory tract pathogens. Biopolymers 71(3): 297
Tandorj, R.K.; Garg, P.K.; Khanna, S.; Madan, K.; Pande, G.K.; Bohidar, N. 2002: Development of organ failure and mortality depend on the extent of pancreatic necrosis in patients with acute severe necrotizing pancreatitis. Gastroenterology 122(4 Suppl 1): A 27
Lang, J.; Wood, S.C. 1999: Development of orphan vaccines: an industry perspective. Emerging Infectious Diseases 5(6): 749-756
Yamane, T.; Kunisada, T.; Yamazaki, H.; Hayashi, S. 2000: Development of osteoclast lineage Approaches using in vitro differentiation system of embryonic stem cells. Journal of Bone and Mineral Research 15(Suppl 1): S390
Tucke, A.G.; Diecidue, R.J. 2004: Development of osteomyelitis after direct laryngoscopy. Anesthesiology 100(4): 1021-1023
Moolenaar, W.H. 2000: Development of our current understanding of bioactive lysophospholipids. Annals of the new York Academy of Sciences 905: 1-10
Branquart, E.; Hemptinne, J.L.uis 2000: Development of ovaries, allometry of reproductive traits and fecundity of Episyrphus balteatus. European Journal of Entomology 97(2): 165-170
Barry, D.M.; Herholdt, G.; Visser, A.; Owiny, D.; De Beer, M.; Murray, G. 2004: Development of ovine embryos and embryonic inner cell mass cells under micro-gravity conditions at the International Space Station. Reproduction Fertility and Development 16(4): 511
Scheiber, S.M.; Robacker, C.D. 2001: Development of ovule culture techniques for breeding interspecific hybrids among Abelia species. HortScience 36(3): 584
Chistyakova, V.R.; Toropchina, L.V.; Chumicheva, I.V. 2001: Development of ozena in a child suffering from anhydrotic ectodermal dysplasia. Vestnik Otorinolaringologii 1: 48-49
Kuehne, C.; Kujath, K.; Kekow, M.; Kekow, J. 2000: Development of p-ANCA during etanercept therapy in rheumatoid arthritis. Clinical and Experimental Immunology 120(Suppl 1): 61
Konya,T.; Omori,S. 2010: Development of packaging equipment for strawberries - test equipment for grading and tray-packing of a peduncle-grip-type tray. Journal Of The Japanese Society Of Agricultural Machinery: 1, 80-85
Conlin, T.; Difede, J.; O'neill, A.M.; Fisher, D.R.; Rabbitts, A.G.; Dembicki, R.; Laznick, H.; Himel, H.; Yurt, R.W. 1999: Development of pain management guidelines in a burn center A pilot study. Journal of Burn Care and Rehabilitation 20(1 Part 2): S267
Vogelmann, R.; Ruf, D.; Wagner, M.; Wenger, C.; Gress, T.; Adler, G.; Menke, A. 1999: Development of pancreatic fibrosis in a TGFbeta 1 transgenic mouse. Gastroenterology 116(4 Part 2): A1174
Popovic Hadzija, M.; Korolija, M.; Hadzija, M.H. 2003: Development of pancreatic precursor cells from mouse embryonic stem cells in vitro. Analytical Cellular Pathology 25(5-6): 301
Roethy, W.K.; Oezpeker, C.; Schima, H.; Grimm, M.; Wolner, E.; Wieselthaler, G. 2004: Development of panel reactive antibodies following continuous flow MicroMed-DeBakey VAD implantation and subsequent effects on allograft rejection. Journal of Heart and Lung Transplantation 23(2S): S109
Vijayalakshmi,R.; Malathi,D. 2010: Development of papaya fortified spaghetti to combat vitamin A deficiency. Acta Horticulturae 851: 571-578
Bushman, M.J.; Webb, E.G.; Marmion, M.E.; Nash, M.M.; Grizio, J.; Roberts, R.A. 2000: Development of parabens as a bacteriostat for use with the Mallinckrodt 99Mo/99mTc generator. Journal of Nuclear Medicine 41(5 Suppl): 251P
Goolsby, J.A.; Ciomperlik, M.A. 1999: Development of parasitoid inoculated seedling transplants for augmentative biological control of silverleaf whitefly. Florida Entomologist 82(4): 532-545
Subhadra, B.; Hurwitz, I.; Fieck, A.; Rao, D.V.S.; Subba Rao, G.; Durvasula, R. 2010: Development of paratransgenic Artemia as a platform for control of infectious diseases in shrimp mariculture. Journal of Applied Microbiology 108(3): 831-840
Li, X.; Li, X.; Zhou, Y.; Liu, Y.; Guo, M.; Zhu, Q.; Xie, Y.; Fan, Z. 2010: Development of patch and spray formulations for enhancing topical delivery of sinomenine hydrochloride. Journal of Pharmaceutical Sciences 99(4): 1790-1799
Holbrook, C.C.; Wilson, D.M.; Lamb, M.; Kvien, C.K.; Guo, B.; Ingram, K.T.; Rowland, D.L. 2002: Development of peanut germplasm with enhanced resistance to preharvest aflatoxin contamination. Mycopathologia 155(1-2): 80
Anzai, H.; Aoki, M.; Tsunoda, K.; Ota, T.; Fujii, Y.; Koyasu, S.; Amagai, M.; Nishikawa, T. 2002: Development of pemphigus vulgaris mouse model by adoptive transfer of naive lymphocytes from Dsg3 knockout mouse. Journal of Investigative Dermatology 119(1): 318
Evans, E.R.; Sutton, J.M.; Shone, C.C. 2002: Development of peptide inhibitors of botulinum toxin using a phage display technique. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 2): R19
Charles, I.S.; Arya, D.P. 2002: Development of peptide nucleic acids-aminoglycoside conjugates. Abstracts of Papers American Chemical Society 224(1-2): MEDI 180
Okarvi, S.M. 2002: Development of peptide-based radiopharmaceuticals as tumor imaging agents. Journal of Nuclear Medicine 43(5 Suppl): 369P
Saviano, M.; Zaccaro, L.; Benedetti, E.; Pedone, C.; Del Gatto, A.; Feliciello, A.; Affaitati, A.; Avvedimento, E.V. 2003: Development of peptides able to modulate the interaction of AKAP121 with mithocondria. Biopolymers 71(3): 320
Johnson, R.J.; Maves, S.A. 2004: Development of peptides that augment complement activation. FASEB Journal 18(4-5): Abstract 777
Xie, D.T.; Soloway, R.D.; Qi, O.Y.; Jia, H.; Xu, Y.Z.; Wu, J.G.; Xu, G.X. 1999: Development of periodic precipitation in an agar gel diffusion system containing both bilirubinate and deoxycholate. Gastroenterology 116(4 Part 2): A34-A35
Eyrich, M.; Croner, T.; Leiler, C.; Lang, P.; Klingebiel, T.; Niethammer, D.; Schlegel, P.G. 2000: Development of peripheral T cell receptor repertoire complexity after mismatched stem cell transplantation in children. Immunobiology 203(1-2): 234-235
Salaun, P.; Parthasarathy, N.; Lagger, G.; Martin, M.; Buffle, J.; Thiebaud, P.; Koudelka, M.; Van Leeuwen, H.P. 2000: Development of permeation liquid membrane systems for in situ trace metal speciation in water. Abstracts of Papers American Chemical Society 220(Part 1): ENVR 137
Lozytska, R.N.; Kuz'min, V.E.; Lozitsky, V.P.; Artemenko, A.G.; Fedchuk, A.S.; Vanden Eynde, J.J. 2002: Development of perspective antiviral compounds by means of 4D-QSAR. International Journal of Antimicrobial Agents 19(Suppl 1): S70
Southward, E.C. 1999: Development of perviata and vestimentifera. Hydrobiologia 402: 185-202
Saragovi, H.U.; Gehring, K. 2000: Development of pharmacological agents for targeting neurotrophins and their receptors. Trends in Pharmacological Sciences 21(3): 93-98
Russell, W.M.; Klaenhammer, T.R. 2000: Development of phospho-alpha- -glucosidase, treA, and a novel beta-glucuronidase gene as reporter genes for lactobacilli. Abstracts of the General Meeting of the American Society for Microbiology 100: 372
Kuchida, K.; Hasegawa, M.; Suzuki, M.; Miyoshi, S. 2001: Development of photographing equipment for the cross section of carcass and prediction of beef color standard number by using obtained image from that equipment. Journal of Dairy Science 84(Suppl 1): 440
Kobayashi, K.; Usami, N.; Maezawa, H.; Hayashi, T.; Hieda, K.; Takakura, K. 2003: Development of photon microbeam irradiation system for radiobiology. Shibata, Yoshisada, Yamashita, Shunichi, Watanabe, Masami, Tomonaga, Masao Radiation and humankind: 207-211
Caamano, J.N.; Wu, G.M.; Mccauley, T.C.; Cantley, T.C.; Rieke, A.R.; Mao, J.; Farwell, R.; Didion, B.A.; Murphy, C.; Day, B.N. 2003: Development of pig embryos in culture media containing HEPES Preliminary results. Journal of Animal Science 81(Suppl 2): 89
Meeran, D.; Urbanski, H.F.; Gregory, S.J.; Brooks, J.; Mcneilly, A.S.; Tortonese, D.J. 1999: Development of pituitary gonadotrophs and lactotrophs in the rhesus monkey. Journal of Reproduction and Fertility Abstract Series 23: 15-16
Miglino, M.A.; Verechia, F.T.; Carvalho, A.F.; Bevilacqua, E. 2001: Development of placenton in a water buffalo. FASEB Journal 15(5): A718
Vo, H.C.; Chu, K.; Kobayashi, J.; Henning, P.; Bryant, M.; Sacks, S.L. 2001: Development of plasma assays for the enantioseparation of L-nucleosides in plasma by high performance capillary electrophoresis. Antiviral Research 50(1): A79
Kikukawa, N.; Okuda, M.; Minami, S.; Ohta, Y.; Uemura, Y.; Fujisawa, M. 2001: Development of plasma-FDP reagent for latex turbidimetric assay. Clinical Chemistry 47(S6): A167
Ballington, J.R.; Shuman, J.L.; Smith, B.J. 1999: Development of plasticulture strawberry cultivars for the mid- and upper South. HortScience 34(5): 833
Carr, M.E. 2003: Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochemistry and Biophysics 38(1): 55-78
King, S.M.; Reed, G.L. 2002: Development of platelet secretory granules. Seminars in Cell and Developmental Biology 13(4): 293-302
Okamoto, G.; Tada, H.; Hirano, K. 1999: Development of pollen tube transmitting tissue influences berry setting of grapes. American Journal of Enology and Viticulture 50(2): 225
Najman, A.; Van Den Akker, J.; Portnoi, M.F.; Chaumarel, I. 2003: Development of polycythemia vera in a patient with chronic myeloid leukemia treated by imatinib mesylate. Blood 102(11): 311b
Mauriello, G.; Casaburi, A.; Villani, F. 2003: Development of polyethylene films for food packaging activated with a food-grade antilisterial bacteriocin. FEMS Congress of European Microbiologists Abstract Book 1: 30-31
Deng, M.; He, J.G.; Weng, S.P.; Lu, L.; Wang, Y.Q.; Long, Q.X.; Chan, S.M. 2003: Development of polymer chain reaction and nucleic acid probe diagnostic methods for the detection of infectious spleen and kidney necrosis virus from mandarin fish. Phillips, Bruce , Reprint Author, Megrey, Bernard A, Zhou, Y Proceedings of the Third World Fisheries Congress: Feeding the world with fish in the next millenium - the balance between production and environment: 181-188
ShaoPanFeng; ChenHongYing; CuiBaoAn; WangZhengYa; SongYaPeng; LiSen; XieJiaXi 2010: Development of polymerase chain reaction for rapidly detecting infectious laryngotracheitis virus. Journal Of Anhui Agricultural University: 1, 58-62
Koch, J.T.; Borovik, A.S. 2001: Development of polymeric materials for use in sensor technology. Abstracts of Papers American Chemical Society 222(1-2): ANYL48
Kondo, S.I.; Kuzuya, M.; Furukawa, S. 2002: Development of polymeric prodrugs as a therapeutic agent for Alzheimers disease by mechanochemical solid-state polymerization. Current Medicinal Chemistry - Central Nervous System Agents 2(2): 157-173
Beheler, A.S.; Fike, J.A.; Murfitt, L.M.; Rhodes, O.E.J.; Serfass, T.S. 2004: Development of polymorphic microsatellite loci for North American river otters and amplification in related Mustelids. Molecular Ecology Notes 4(1): 56-58
Miyoshi, K.; Rzucidlo, S.J.; Stice, S.L. 2001: Development of porcine activated oocytes and cloned embryos in G12/G22 medium. Biology of Reproduction 64(Suppl 1): 174
Kim, D.Y.; Lee, S.H.; Oh, B.C.; Kim, H.S.; Lee, G.S.; Hyun, S.H.; Park, J.I.; Lee, E.S.; Lim, J.M.; Kang, S.K.; Lee, B.C.; Hwang, W.S. 2002: Development of porcine embryos reconstructed with fetal fibroblasts transfected with green fluorescent protein gene. Cloning and Stem Cells 4(3): 302
Park, K.W.; Kuhholzer, B.; Lai, L.; Machaty, Z.; Day, B.N.; Prather, R.S. 2000: Development of porcine nuclear transfer embryos derived from granulosa cells. Biology of Reproduction 62(Suppl 1): 321
Verma, P.J.; Du, Z.T.; Grupen, C.G.; Crocker, L.A.; Mcilfatrick, S.M.; Ashman, R.J.; Lyons, I.G.; Nottle, M.B. 2002: Development of porcine nuclear transfer embryos following post fusion enucleation. Theriogenology 57(1): 454
Park, K.W.; Kuhholzer, B.; Lai, L.; Day, B.N.; Prather, R.S. 2001: Development of porcine transgenic embryos derived from nuclear transfer of mural granulosa cells. Theriogenology 55(1): 283
Magata, Y.; Ogawa, M.; Saji, H. 2003: Development of positron emitter labeled compounds and their application for biological estimation of therapeutic drugs. Journal of Pharmacological Sciences 91(Suppl I): 23P
Vanbrocklin, H.F.; Gibbs, A.R.; Hanrahan, S.M.; Hom, D.L.; Lim, J.K.; Riese, D.J.II 2000: Development of positron labeled epidermal growth factor receptor tyrosine kinase inhibitors PET probes for breast cancer. Abstracts of Papers American Chemical Society 219(1-2): MEDI 63
Gabbay, E.; Orsida, B.; Taylor, J.; Ward, C.; Whitford, H.; Kotsimbos, T.; Snell, G.I.; Walters, E.H.; Williams, T.J. 1999: Development of post lung transplant obliterative bronchiolitis is characterized by increased exhaled nitric oxide, upregulation of iNOS and downregulation of cNOS. Journal of Heart and Lung Transplantation 18(1): 51
Kirsch, C.; Miehlke, S.; Morgner, A.; Vieth, M.; Stolte, M.; Jacobs, E.; Lehn, N.; Bayerdoerffer, E. 2001: Development of post-treatment antimicrobial resistance after treatment failures of Helicobacter pylori infection. Gut 49(Suppl 11): A89
Wallentin, N.; Lundgren, B.; Holmen, J.B.; Lundberg, C. 1999: Development of posterior capsule opacification do not differ between phacoemulsification and extracapsular cataract extraction in the rabbit. IOVS Investigative Ophthalmology and Visual Science 40(4): S294
Vinay, L.; Brocard, F.; Clarac, F.; Norreel, J.C.; Pearlstein, E.; Pflieger, J.F. 2002: Development of posture and locomotion An interplay of endogenously generated activities and neurotrophic actions by descending pathways. Brain Research Reviews 40(1-3): 118-129
Aspiotis, R.; Bayly, C.; Becker, J.W.; Ethier, D.; Francouer, S.; Margarita, G.C.; Giroux, A.; Grimm, E.L.; Han, Y.; Mckay, D.J.; Nicholson, D.W.; Peterson, E.; Rasper, D.M.; Renaud, J.; Rotonda, J.; Roy, S.; Tam, J. 2002: Development of potent and selective caspase-3 inhibitors. Abstracts of Papers American Chemical Society 224(1-2): MEDI 270
Bacha, U.M.; Barrila, J.A.; Velazquez Campoy, A.; Leavitt, S.; Freire, E. 2004: Development of potent inhibitors of the SARS associated coronavirus protease 3CLpro. Biophysical Journal 86(1): 97a
Senter, P.D.; Doronina, S.; Meyer, D.; Francisco, J.; Wahl, A. 2003: Development of potent monoclonal antibody auristatin conjugates for the treatment of cancer. Inflammation Research 52(Suppl 2): S 81
Slee, D.H.; Romano, S.J.; Yu, J.; Nguyen, T.N.; Raheja, N.R.K.; John, J.K.; Axe, F.U.; Jones, T.K.; Ripka, W.C. 2001: Development of potent non-carbohydrate small molecule selectin inhibitors. Abstracts of Papers American Chemical Society 221(1-2): MEDI 21
Arrighi, J.F.; Pion, M.; Wiznerowicz, M.; Geijtenbeek, T.B.; Garcia, E.; Van Kooyk, Y.; Trono, D.; Piguet, V. 2004: Development of potential microbicides based on RNA interference of DC-SIGN. Journal of Investigative Dermatology 123(2)
Walker, A.S.; Garcia, A.L.; Yanko, W.A. 1999: Development of practical monitoring techniques to identify the probability of the presence of pathogens in receiving waters. Abstracts of the General Meeting of the American Society for Microbiology 99: 598
Reece, W.H.H.; Gothard, P.; Moorthy, V.; Watkins, K.; Arulanantham, N.; Roberts, M.T.M.; Schneider, J.; Hannan, C.; Gilbert, S.C.; Plebanski, M.; Hill, A.V.S. 2000: Development of pre-erythrocytic stage vaccines against Plasmodium falciparum malaria. Immunology 101(Suppl 1): 36
Chen, Y.; Wu, L.-p.; Chen, C.; Ye, L.-m. 2010: Development of predictive quantitative retention-activity relationship models of alkaloids by mixed micellar liquid chromatography. Biomedical Chromatography: Bmc 24(2): 195-201
Leppert, M.; Visintainer, P.F.; Accardo, P.J. 2003: Development of premature infants. Pediatric Research 53(4 Part 2): 459A
Brockbank, K.G.M.; Song, Y.C.; Walsh, J.R.; Taylor, M.J. 2003: Development of preservation methods for cellular engineered tissues. International Journal of Artificial Organs 26(9): 818
Wu, T.C. 2000: Development of preventive and therapeutic vaccines for HPV-associated cancers. Proceedings of the American Association for Cancer Research 41: 890
Daczewska, M. 2000: Development of primary and secondary muscle fibres in the myotomes of Rana lessonae. Acta Biologica Cracoviensia Series Botanica 42(Suppl 1): 39
Morikawa, K.; Ito, K. 1999: Development of primary neurons in lamprey embryos. Zoological Science 16(Suppl ): 73
Laube,I.; Hird,H.; Brodmann,P.; Ullmann,S.; Schone-Michling,M.; Chisholm,J.; Broll,H. 2010: Development of primer and probe sets for the detection of plant species in honey. Food Chemistry 8(4): 979-986
Umeda, K.; Heike, T.; Yoshimoto, M.; Shiota, M.; Suemori, H.; Luo, H.Y.; Chui, D.H.K.; Torii, R.; Shibuya, M.; Nakatsuji, N.; Nakahata, T. 2004: Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development 131(8): 1869-1879
Tamori, Y.; Wakahara, M. 2003: Development of primordial germ cells in the Japanese newt Cynops pyrrhogaster. Zoological Science (Tokyo) 20(12): 1554
Evans, D. 2001: Development of products that impact gene expression. Abstracts of Papers American Chemical Society 222(1-2): AGFD137
Rhodes, D.R.; Chinnaiyan, A.M.; Rubin, M.A. 2003: Development of prostate cancer biomarkers to indentify men suitable for watchful waiting protocols. Modern Pathology 16(1): 166A
D.V.ies, S.H.; Raaijmakers, R.; Kranse, R.; Wildhagen, M.F.; Schroder, F.H. 2004: Development of prostate specific antigen over time in males with screen detected adenocarcinoma of the prostate following a watchful waiting policy. Journal of Urology 171(4 Suppl): 482-483
Gao, C.L.; Liu, A.; Ali, A.; Connelly, R.R.; Mcleod, D.G.; Moul, J.W.; Srivastava, S. 2004: Development of prostate tissue and/or prostate cancer specific gene panel for defining circulating prostate epithelial cells. Journal of Urology 171(4 Suppl): 170-171
Choi, Y.S.; Min, K.S.; Pack, S.P.; Yoo, Y.J. 2002: Development of protein microarray using DNA chip. Abstracts of Papers American Chemical Society 224(1-2): BIOT 242
Yamamoto, I. 2004: Development of provitamin C agents, AA-2G and 6-Acyl-AA-2G, for the basic science research and clinical applications. Vitamins 78(3): 127-140
Rodriguez, F.; Arroyo, J.I.; Toro, D. 2001: Development of psychiatric side effects in US Veteran patients with chronic Hepatitis C after treatment with Interferon and Ribavirin compared to Non-Veteran patients. Hepatology 34(4 Pt 2): 594A
Hibbeln, J.R.; Bulka, S.; Yolken, R.; Klebanoff, M.; Majchrzak, S.; Salem, N.Jr 2001: Development of psychotic illnesses among children and maternal plasma EFA composition sampled at birth. Journal of Molecular Neuroscience 16(2-3): 325-326
Rusconi, R.; Carlucci, P.; Appiani, A.; Dacco, V.; Testa, S.; Bozzola, M. 2000: Development of puberty and its role in chronic renal failure. Hormone Research 53(Suppl 2): 93
Wilberding, J.A.; Ploplis, V.A.; McLennan, L.; Liang, Z.; Cornelissen, I.; Feldman, M.; Deford, M.E.; Rosen, E.D.; Castellino, F.J. 2001: Development of pulmonary fibrosis in fibrinogen-deficient mice. Annals of the new York Academy of Sciences 936: 542-548
Hornsey, V.; Drummond, O.; Pepper, D.; Macgregor, I. 2000: Development of purification methods for platelet prion protein. Vox Sanguinis 78(Suppl 1): P359
Shimeld, S.M.; Mazet, F.; Graham, A. 2004: Development of putative placode homologs in Ciona intestinalis. Journal of Morphology 260(3): 329
Shepson, P.B.; Hurst, J.M.; Barket, D.J.; Colorado, A. 1999: Development of quadrupole ion trap methods for determination of atmospheric volatile organic compounds. Abstracts of Papers American Chemical Society 217(1-2): ANYL 127
Vitkus, D.; Kucinskiene, Z.A. 1999: Development of quality assurance system in Laboratory of Biochemistry of Vilnius University Hospital. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S301
Iniesta Navalon, C.; Llopis Salvia, P. 2003: Development of quality control system for the preparation of cytostatic drugs. Atencion Farmaceutica 5(6): 388-390, 392-396
Lapane, K.L.; Hume, A.; Owens, N.; Gifford, D.; Mor, V. 2000: Development of quality indicators based on medication use for US nursing homes. Pharmacoepidemiology and Drug Safety 9(Suppl 1): S106
Cheng, E.M.; Siderowf, A.; Swarztrauber, K.; Eisa, M.; Lee, M.; Vickrey, B.G. 2004: Development of quality of care indicators for Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 19(2): 136-150
Seo, K.; Lee, D.S.; Ahn, J.Y.; Paeng, J.C.; Lee, J.S.; Cheon, G.J.; Yeo, J.S.; Noh, T.W.; Chung, J.K.; Lee, M.C. 2001: Development of quantification method for renal cortical blood flow using factor analysis on 15O water dynamic PET and validation by canine experiment. Journal of Nuclear Medicine 42(5 Suppl): 11P
Kato, T.; Mizokami, M.; Mukaide, M.; Orito, E.; Tomoyoshi, O.; Nakano, T.; Tanaka, Y.; Kato, H.; Sugauchi, F.; Hirashima, N.; Kage, M. 1999: Development of quantification system for TT virus DNA using real time detection PCR. Hepatology 30(4 Part 2): 292A
Gress, C.J.; James, I.E.; Dada, N.; Gowen, M.; Lark, M.W. 2001: Development of quantitative ELISAs to pro- and mature cathepsin K Their utility in mechanistic studies of osteoclastic bone resorption. Journal of Bone and Mineral Research 16(Suppl 1): S265
Isbell, L.; Healy, E.F. 2003: Development of quantitative assay for Glutathione Reductase. Abstracts of Papers American Chemical Society 225(1-2): CHED 878
Forsberg, N.; Puntenney, S.; Wang, Y. 2003: Development of quantitative diagnostic assays for assessment of mycotic infections. Journal of Dairy Science 86(Suppl 1): 251
Chen Xiaoyou; Ma Yu 2001: Development of quantitative polymerase chain reaction technique. Zhonghua Jiehe He Huxi Zazhi 24(3): 184-188
Andricopulo, A.D.; Yunes, R.A. 2001: Development of quantitative structure-activity relationships for a series of inhibitors of purine nucleoside phosphorylase. Abstracts of Papers American Chemical Society 222(1-2): MEDI79
Phillips, R.M. 2001: Development of quinone based bioreductive drugs in the aftermath of EO9 Is there a future?. International Journal of Molecular Medicine 8(Suppl 1): S84
Hosoi, Y.; Takahashi, M.; Higashide, S.; Matsumoto, K.; Saeki, K.; Iritani, A.; Miyano, T. 2003: Development of rabbit preantral follicles isolated from ovaries of sexually matured doe in the SCID mice. Theriogenology 59(1): 408
WangBaoTong; HuXiaoPing; LiQiAng; HaoBaoJun; ZhangBo; LiGaoBao; KangZhenSheng 2010: Development of race-specific SCAR markers for detection of Chinese races CYR32 and CYR33 of Puccinia striiformis f sp tritici. Plant Disease: 2, 221-228
Soga, S.; Shiotsu, Y.; Akinaga, S.; Sharma, S.V. 2003: Development of radicicol analogues. Current Cancer Drug Targets 3(5): 359-369
Balogh, L.; Cook, A.C.; Baker, J.R.Jr; Khan, M.K. 2002: Development of radioactive dendrimer nanocomposites. Journal of Nuclear Medicine 43(5 Suppl): 135P
Balogh, L.; Nigavekar, S.S.; Cook, A.T.; Minc, L.; Khan, M.K. 2003: Development of radioactive dendrimer nanocomposites to treat tumor microvasculature. Abstracts of Papers American Chemical Society 225(1-2): NUCL 136
Balogh, L.P.; Nigavekar, S.S.; Sung, L.Y.; Balogh, P.; Shi, X.Y.; Cook, A.T.; Minc, L.D.; Khan, M.K. 2003: Development of radioactive gold-dendrimer nanocomposite devices to treat tumor microvasculature Synthesis and biodistribution. Journal of Nuclear Medicine 44(5 Suppl): 305P-306P
Okada, R.; Yamamoto, K.; Kikuyama, S. 2002: Development of radioimmunoassay for bullfrog TSHbeta subunit Effect of TRH on the release of immunoassyable TSHbeta from the bullfrog pituitary. Zoological Science 19(12): 1494
Sloan, J.; Green, N.; Mistry, J.; Gingerich, R. 2003: Development of radioimmunoassays to measure different molecular forms of ghrelin. Diabetes 52(Suppl 1): A214
Van Dort, M.E.; Jung, Y.W.; Sherman, P.S.; Kuszpit, K.K. 2001: Development of radioiodinated nonsteroidal androgen receptor ligands for SPECT imaging of prostate cancer. Journal of Labelled Compounds and Radiopharmaceuticals 44(Suppl 1): S327-S329
Su, Z.; Shen, Y.; Alberini, J.; Guan, L.; Berezov, A.; Alavi, A.; Murali, R. 2003: Development of radiolabeled peptides for ErbB relevant tumors imaging. Journal of Nuclear Medicine 44(5 Suppl): 302P
Skovronsky, D.M.; Kung, M.P.; Zhang, B.; Kung, H.; Trojanowski, J.Q.; Lee, V.M.Y. 2001: Development of radioligands for in vivo imaging of brain amyloid. FASEB Journal 15(4): A391
Cheng, J.J.; Yu, C. 1999: Development of radionuclide partitioning factors for use in the dose assessments concerning recycling of radioactively contaminated aluminum scrap metal. Health Physics 76(6 Suppl): S183
Ryu, J.M.; Seong, S.K.; Bae, E.J.; Jo, E.H.; Lee, J.T.; Lee, J.D.; Han, K.H.; Shin, B.C.; Park, K.B. 2003: Development of radiopharmaceutical using 166Ho-chitosan complex for anticancer agent. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S309
Okamura, T.; Kikuchi, T.; Nagamine, A.; Fukushi, K.; Arano, Y.; Irie, T. 2003: Development of radiotracers for measuring cerebral redox state using redox conversion of dihydropyridine-pyridinium salt and metabolic trapping principle. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S174
Lu, C.; Zhang, W.; Peng, X.; Gu, G.; Chen, M.; Tang, Z. 2010: Development of randomly amplified polymorphic DNA-sequence characterized amplified region marker for identification of Apocynum venetum LINN. from A. pictum SCHRENK. Biological and Pharmaceutical Bulletin 33(3): 522-526
Kumar, A.; Kalra, B.; Byerly, J.; Bodani, U. 2004: Development of rapid INTACT hCG enzyme-linked immunosorbent chemiluminiscent assay. Clinical Chemistry 50(6, Suppl S, Part 2): A86
Kalra, B.; Kumar, A.; Byerly, J.; Khaja, N.; Bodani, U. 2004: Development of rapid PAPP-A enzyme-linked immunosorbent chemiluminiscent assay. Clinical Chemistry 50(6, Suppl S, Part 2): A96
Boga, R. 2001: Development of rapid and sensitive enzyme immunoassay for estrone sulfate. Clinical Chemistry 47(S6): A21
Boga, R. 2001: Development of rapid and sensitive radiometric and enzyme immuno-assays for corticosterone. Clinical Chemistry 47(S6): A20-A21
Takahata, Y.; Kamiya, K.; Mastumoto, T.; Sato, T.; Shibata, R.; Morimatsu, F. 2004: Development of rapid and simple diagnostic kits for food allergens by immunochromatography. Journal of Allergy and Clinical Immunology 113(2 Suppl): S237
Shimojima, M.; Masui, Y.; Kawaguchi, T.; Nakamura, S.; Seto, I.; Suzuki, H. 1999: Development of rapid automatic streaking system using multi-jointed robot. Abstracts of the General Meeting of the American Society for Microbiology 99: 393
Miwa, Y.; Tanaka, J.; Goto, K. 2002: Development of rapid double stable transfection system. Japanese Journal of Pharmacology 88(Suppl 1): 173P
Van Herwynen, J.F.; Trubetskoy, O.V.; Lowery, R.G. 2000: Development of rapid glucuronidation screening methods with isolated recombinant UGT isozymes. Drug Metabolism Reviews 32(Suppl 1): 114
Sharma, H.S.S.ekhar; Mccall, R.D.; Kernaghan, K. 2003: Development of rapid techniques for assessing physical properties of modified linen fabric. Abstracts of Papers American Chemical Society 225(1-2): CELL 135
Birks, N.J.; Minehart, H.W.; Chalker, A.F.; Hoffman, P.S. 2000: Development of rapid, high-throughput MIC assay for Helicobacter pylori. Gut 47(Suppl 1): A14
Schirmer, K.; Wober, J.; Schreer, A.; Caldarelli, A.; Vollmer, G. 2003: Development of rat and fish liver nucleotide arrays for studying gene expression in response to estrogenic compounds. Toxicology Letters (Shannon) 144(Suppl 1): s53-s54
Miller, S.J.; Sheridan, K.M.; Ferguson, M.J.; Labarrere, C.A.; Unthank, J.L. 2004: Development of rat aorta intimal pathology is age and strain dependent. FASEB Journal 18(4-5): Abstract 789
Kouki, T.; Imai, H.; Aoto, K.; Eto, K.; Shioda, S.; Kawamura, K.; Kikuyama, S. 2000: Development of rat pituitary primordium before and after Rathkes pouch formation. Zoological Science 17: 10
Kubova, H.; Haugvicova, R.; Mares, P. 1999: Development of rat pups is impaired by status epilepticus. Epilepsia 40(Suppl 2): 149
Brelinska, R.; Ostalska, D.; Jaroszewski, J. 2000: Development of rat thymic medulla during ontogeny. Immunology Letters 73(2-3): 121
Gardezi, A.; Malloy, P.; Feldman, D.; Peleg, S. 2000: Development of rational strategy for treatment of hereditary vitamin D-resistant rickets with analogs of 1,25-dihydroxyvitamin D3. Journal of Bone and Mineral Research 15(Suppl 1): S153
Horita, N. 2003: Development of re-expandable covered stent for children. Circulation 108(17): IV678
Sidoti, F.; Rizzo, F.; Costa, C.; Astegiano, S.; Curtoni, A.; Mandola, M.L.; Cavallo, R.; Bergallo, M. 2010: Development of real time RT-PCR assays for detection of type a influenza virus and for subtyping of avian H5 and H7 hemagglutinin subtypes. Molecular Biotechnology 44(1): 41-50
Smith, R.H.; Henderson, B.; Lancaster, W.D.; Hudson, A.P.; Downward, J.G.Iv; Erb, J.L. 2000: Development of real-time DNA hybridization assays using fiber optic sensors. Abstracts of Papers American Chemical Society 220(Part 1): ANYL 58
Galan, A.M.G.; Brohee, M.; Scaravelli, E.; Hengel, A.J.; Chassaigne, H. 2010: Development of real-time PCR assays for the detection of lupin residues in food products. European Food Research And Technology 2010(4): 597-608
Szabo, L.J.; Barnes, C.W.; Nguyen, K.P. 2003: Development of real-time PCR assays for the detection of stem and leaf rust pathogens of wheat. Phytopathology 93(6 Suppl): S82
Stenzel, T.T.; Wikstrand, C.J.; Mclendon, R.E.; Kuan, C.T.; Wakiya, K.; Friedman, H.S.; Bigner, D.D. 2002: Development of real-time PCR assays for the proper selection of EGFR targeted small molecular and immunotoxin therapies for malignant gliomas. Proceedings of the American Association for Cancer Research 43: 747
SunFeiLong; WuDaoCheng; QiuZhiGang; JinMin; WangXinWei; LiJunWen 2010: Development of real-time PCR systems based on SYBR Green for the specific detection and quantification of Klebsiella pneumoniae in infant formula. Food Control: 4, 487-491
Wang, C.Y.; Giambrone, J.; Smith, B. 2002: Development of real-time PCR to study replication kinetics of Duck hepatitis B virus in cell culture. Poultry Science 81(Suppl 1): 161
Dawson, H.D.; Beshah, E.; Nishii, S.; Lunney, J.K.; Urban, J.F. 2002: Development of real-time RT-PCR assays for porcine cytokine gene expression. FASEB Journal 16(4): A679
Takai, Y.; Mitsuya, M.; Nemoto, K.; Ogawa, Y.; Ariga, H.; Takeda, K.; Takahashi, C.; Yamada, S.; Mostafavi, H.; Marc, M.; Antwerp, C.V.; Mansfield, S. 2002: Development of real-time tumor tracking system with dMLC with dual x-ray fluoroscopy and amorphous silicon flat panel on the gantry of linear accelerator. International Journal of Radiation Oncology Biology Physics 54(2 Suppl): 193-194
Xu, X.G.; Chao, T.C.; Eckerman, K.F. 1999: Development of realistic body models for organ dose calculations. Health Physics 76(6 Suppl): S160
Li, W.P.; Smith, C.J.; Cutler, C.S.; Ketring, A.R.; Jurisson, S.S. 2000: Development of receptor-based radiopharmaceuticals using carrier-free promethium-149 Syntheses, in vitro stability studies, and in vivo biodistribution studies of DTPA, DOTA, and DTPA-Octreotide complexes. Journal of Nuclear Medicine 41(5 Suppl): 246P
Bartlett, J.S.; Smith Arica, J.R.; Arnold, G.; Shi, W. 2001: Development of receptor-targeted adeno-associated virus vectors for the treatment of cystic fibrosis. Pediatric Research 49(4 Part 2): 187A
Bandyopadhyay, D.; Hyland, S.; Singh, R.; Wels, W. 2002: Development of recombinant MUC1-single chain antibody for in vivo imaging and targeted therapy in breast cancer. International Journal of Cancer Suppl (13): 88
Fogler, W.E.; Yim, Z.; Chen, T.; Chen, B.; Leffers, N.; Sidor, C.; Fortier, A.H.; Jackson, D.; Plum, S.M.; Kough, E.; Sim, B.K.m Lee 2002: Development of recombinant human endostatin in SOS to support clinical subcutaneous administration. Proceedings of the American Association for Cancer Research 43: 179
Arvin, A.M.; Mallory, S.; Moffat, J.F. 1999: Development of recombinant varicella-zoster virus vaccines. Contributions to Microbiology 3: 193-200
Whitt, M.A.; Jayakar, H.R.; Wright, S.; Tanzer, G.; Bauler, M.; Robison, C.S.; Steiner, M.S. 2001: Development of recombinant vesicular stomatitis virus as a novel targeting gene delivery system. Gene Therapy 8(Suppl 1): S13
Edwards, J.L.; Powell, A.M.; Talbot, N.C.; Garrett, W.M.; Pursel, V.G. 1999: Development of reconstructed embryos activated immediately or 4 hours after assessment of fusion with fetal fibroblasts. Theriogenology 51(1): 202
Lee, G.S.; Hyun, S.H.; Kim, H.S.; Kim, D.Y.; Lee, S.H.; Oh, B.C.; Park, J.I.; Lim, J.M.; Lee, E.S.; Kang, S.K.; Lee, B.C.; Hwang, W.S. 2002: Development of reconstructed porcine embryos derived from in vivo- or in vitro-matured oocytes as a somatic cell recipient cytoplast. Cloning and Stem Cells 4(3): 293
Trammell, S.A.; Tender, L.M.; Conrad, D.W.; Hellinga, H.W. 2000: Development of redox probes for reagentless biosensors. Abstracts of Papers American Chemical Society 220(Part 1): ANYL 59
Thienpont, L.M. 1999: Development of reference materials for standardizing cortisol measurements. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S115
Trespi, E.; Colla, C.; Venturini, A.; Panizza, P.; Polino, M.G. 2000: Development of reflux esophagitis after Helicobacter pylori eradication in gastritis. Gut 47(Suppl 1): A82-A83
Fukuda, K. 2000: Development of regenerated cardiomyocyte for cardiovascular tissue engineering. Cell Structure and Function 25(6): 396
Garcia, V.D.; Goldani, J.C.; Dominguez, V.; Michelon, T.; Neumann, J.; Keitel, E. 1999: Development of regional transplant programs. Transplantation Proceedings 31(6): 2235-2238
Tinge, S.A.; Sundaram, P.; Godsy, E.; Gort, S.; Curtiss, R.IIi 1999: Development of regulated high-level expression vectors for use in avirulent Salmonella vaccines. Abstracts of the General Meeting of the American Society for Microbiology 99: 292
Luce, M.J.; Reiser, J. 2002: Development of regulated lentivirus vectors. Journal of Investigative Medicine 50(1): 142A
Cayrou, S.; Dolbeault, S. 2002: Development of relaxation techniques in oncology. Bulletin du Cancer 89(10): 845-856
Gorsane, F.; Fekih Hassen, I.; Elleuch, A.; Djilani, F.; Jandoubi, L.; Marrakchi, M.; Fakhfakh, H. 2002: Development of reliable and sensitive detection methods for the diagnosis of major viruses and viroids infecting vegetables, grape and citrus in Tunisia. Phytopathology 92(6 Suppl): S30-S31
Kawahara, K.; Anzai, N.; Suzuki, Y.; Nishikitani, M.; Izumida Moriguchi, I.; Kokubo, A. 2001: Development of renal potassium excretion system in the neonatal rat. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 33A
Kumagai, H.; Kimura, M.; Ikegaya, N. 2001: Development of renal tubulointerstitial lesions in weanling rats with diet-induced chronic hyperhomocysteinemia. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 514A
Mohanty, A.K.; Drzal, L.T.; Wibowo, A.; Misra, M. 2002: Development of renewable resource based bioplastic Effect of eco-friendly citrate plasticizer on the performance of cellulosic plastic. Abstracts of Papers American Chemical Society 223(1-2): POLY 12
Wang, Q.; Hummler, E.; Nussberger, J.; Brunner, H.R.; Burnier, M. 2002: Development of renovascular hypertension in alpha ENaC knockout heterozygous mice. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 331A
Tai, C.K.; Wang, W.; Chen, T.C.; Sazawa, A.; Faure, E.; Logg, C.R.; Bochner, B.H.; Yoon, L.T.K.; Lee, A.S.; Cannon, P.M.; Anderson, W.F.; Kasahara, N. 2003: Development of replication-competent retrovirus vectors for cancer gene therapy In vivo therapeutic efficacy, tumor-selectivity, and safety. Cancer Gene Therapy 10(Suppl 1): S15
Pehrsson, P.; Evans, J.; Trainer, D.; Haytowitz, D.; Holden, J.; Perry, C.; Beckler, D. 1999: Development of representative nutrient data for margarine and spreads under the National Food and Nutrient Analysis Program. FASEB Journal 13(5 Part 2): A888
Li, X.; Howard, Z.R.; Diaz, I.Z.; Medvedev, K.L.; Ricke, S.C. 2002: Development of research paper writing skills of poultry science undergraduate students taking food microbiology. Poultry Science 81(Suppl 1): 105-106
Nutter, B.; Sorenson, J.; Gire, C.; Rydland, M.; Shen, P.; Glanowski, S.; Edwards, N.; Furtado, M.; Guegler, K.; Spier, E.; Fang, R.; Pham, L.Z. 2003: Development of resequencing primer sets for high throughout DNA sequence variation studies. American Journal of Human Genetics 73(5): 432
Mercer, C.F.; Watson, R.N.; Barrett, B.A.; Spangenburg, G.; Van Den Bosch, J.; Moore, K.K. 2003: Development of resistance in clovers for New Zealand pasture. Journal of Nematology 35(3): 354
Krishnaiah, N.V.; Prasad, A.S.R.; Pasalu, I.C.; Kumar, K.M.; Lingaiah, T. 2002: Development of resistance in rice brown planthopper Nilaparvata lugens and green leafhopper Nephotettix virescens to Neem formulation. Pesticide Research Journal 14(1): 01-07
Sazontova, T.G.; Arkhipenko, Y.V. 2001: Development of resistance of cardiac sarcoplasmic reticulum Ca-pump during adaptation to physical load and stress. Journal of Molecular and Cellular Cardiology 33(6): A107
Turner, N.A.; Russell, A.D.; Furr, J.R.; Lloyd, D. 1999: Development of resistance to biocides during differentiation of Acanthamoeba castellanii. Journal of Pharmacy and Pharmacology 51(Suppl ): 34
Nikolova, I.; Galabov, A.S. 2000: Development of resistance to disoxaril in coxsakievirus B1 infected newborn mice. Antiviral Research 46(1): A66
Majlessipour, F.; Kwock, R.; Avramis, V. 1999: Development of resistance to gamma radiation in T-lymphoblastic cell lines after treatment with chemotherapeutic agents. Pediatric Research 45(4 Part 2): 149A
Rafii, F. 2000: Development of resistance to quinolones by anaerobic bacteria from the human intestinal tract. Abstracts of the General Meeting of the American Society for Microbiology 100: 19
Raikow, D.F.; Atkinson, J.F.; Croley Ii, T.E. 2010: Development of resource shed delineation in aquatic ecosystems. Environmental Science and Technology 44(1): 329-334
Mejhert, E.; Olsson, A.; Hardemark, A.; Lagercrantz, H.; Herlenius, E. 2001: Development of respiratory control in mice. Pediatric Research 49(2): 279
Riddell, P.M.; Horwood, A.M.; Houston, S.M.; Turner, J.E. 1999: Development of responses to prism deviation in human infants. IOVS Investigative Ophthalmology and Visual Science 40(4): S55
Soubrane, G.; Kuhn, D.; Quaranta, M.; Coscas, G. 1999: Development of retinal choroidal anastomosis in age-related macular degeneration. IOVS Investigative Ophthalmology and Visual Science 40(4): S378
Steidl, S.M.; Peddada, R. 1999: Development of retinal patch In vitro bonding experiments. IOVS Investigative Ophthalmology and Visual Science 40(4): S733
Fuhrmann, S.; Reh, T.A. 1999: Development of retinal pigment epithelium during early eye formation in the chick embryo. Society for Neuroscience Abstracts 25(1-2): 1545
Teixeira, R.; Barbosa, A.; Godinho, E.; Souza, L.C.; Vilela, E.; Bassetti Soares, E.; Paz, M.; Galizzi Filho, J. 2002: Development of retinal vein occlusion during interferon therapy for chronic hepatitis C. Hepatology 36(4 Part 2): 590A
Freeth, J.S.; Iqball, S.; Rohll, J.; Watt, S.; Lewis, C.E.; Kingsman, S.M.; Naylor, S. 1999: Development of retroviral transduced haematopoietic stem cells toward a novel approach to cancer gene therapy. Biochemical Society Transactions 27(5): A148
Stefani, A.L.; Barzon, L.; Bonaguro, R.; Gnatta, E.; Palu', G.; Farinati, F. 2002: Development of retroviral vectors for combined suicide and immunomodulating gene therapy of hepatocellular carcinoma. Journal of Hepatology 36(Suppl 1): 161
Alexandersen, S.; Forsyth, M.A.; Reid, S.M.; Belsham, G.J. 2001: Development of reverse transcription-PCR enzyme-linked immunosorbent assays for diagnosis and preliminary typing of foot-and-mouth disease A new system using simple and aqueous-phase hybridization. Journal of Clinical Microbiology 38(12): 4604-4613
Mitalipov, S.M.; Nusser, K.D.; Widmann, A.A.; Gerami Naini, B.; Wolf, D.P. 2000: Development of rhesus monkey demi-embryos created by blastomere separation at the 2-cell stage. Theriogenology 53(1): 397
Mitalipov, S.M.; Yeoman, R.R.; Wolf, D.P. 2002: Development of rhesus monkey embryonic and somatic cell nuclear transfer embryos. Theriogenology 57(1): 434
Guermazi, M.; Poiraudeau, S.; Lefevre-Colau, M.M.; Revel, M. 2003: Development of rheumatoid arthritis functional handicap assessment questionnaire: preliminary study. Annales de Readaptation et de Medecine Physique: Revue Scientifique de la Societe Francaise de Reeducation Fonctionnelle de Readaptation et de Medecine Physique 46(5): 241-248
Johnson, V.; Gibbons, J.; Moldenhauer, K.; Wang, Z.; Jia, Y. 2003: Development of rice cultivars with improved blast resistance using marker assisted selection. Phytopathology 93(6 Suppl): S41
Hoven, H.M.; Long, R.E. 2002: Development of riparian habitat at the Pabco Road erosion control structure on Las Vegas Wash, Clark County, Nevada. Ecological Society of America Annual Meeting Abstracts 87: 162
Zelinski, P.D.; Vuocolo, L.D. 2002: Development of robust iron complexes for catalyzing biologically relevant oxidations. Abstracts of Papers American Chemical Society 223(1-2): CHED 513
Hendrickson, A.E.; Westrum, L.E. 2000: Development of rod bipolar and amacrine synapses in monkey inner plexiform layer. IOVS Investigative Ophthalmology and Visual Science 41(4): S848
Soukup, A.; Votrubova, O.; Eikova, H. 2000: Development of root tissues of Phragmites australis Effect of nutrient supply. Plant Physiology and Biochemistry (Paris) 38(Suppl): s141
Crewther, S.G.; Gibbie, T.; Crewther, D.P. 2000: Development of saccadic suppression. IOVS Investigative Ophthalmology and Visual Science 41(4): S730
Mir, N.A.; Beaudry, R.M. 2000: Development of safe working atmospheres for enhanced storage of horticultural crops. HortScience 35(3): 469
Arens, S.; Heiber, W. 1999: Development of salt marsh vegetation in the Leybucht from 1948 to 1996. Senckenbergiana Maritima 29(Suppl): 7-11
Wu, W.; Lookingland, K.J.; Wang, D.H. 2000: Development of salt sensitive hypertension induced by sensory denervation Role of sympathetic nerves. FASEB Journal 14(4): A95
Chiappini Williamson, C.; Candea, C.M.; Salisbury, R.L. 2001: Development of satellite cells and mitosis of neuronal and non neuronal cells in the superior cervical ganglion of the neonatal male rat. Ohio Journal of Science 101(1): A 33
Banik, G.G.; Broad, D.; Lin, A. 2000: Development of scalable manufacturing processes for deltaE1deltaE4 adenoviral vectors. Abstracts of Papers American Chemical Society 219(1-2): BIOT 103
Rensen, P.C.N.; Moor, A.C.E.; Gras, J.C.E.; Lindfors, E.K.; Dubbelman, T.M.A.R.; Kuiper, J.; Jukema, J.W.; Van Berkel, T.J.C.; Biessen, E.A.L. 1999: Development of scavenger receptor class A-specific liposomes for the selective delivery of aluminium phthalocyanine to macrophages. Photochemistry and Photobiology 69(SPEC ISSUE ): 43S
Gobel, J.; Saussy, D.L.; Goetz, A.S. 2000: Development of scintillation-proximity assays for alpha adrenoceptors. Journal of Pharmacological and Toxicological Methods 42(4): 237-244
Benedek, G.; Benedek, K.; Keri, S.; Janaky, M. 2001: Development of scotopic spatial contrast sensitivity functions and contour integration ability in children. IOVS Investigative Ophthalmology and Visual Science 42(4): S388
Siziopikou, K.P.; Soldat Schumacher, S.; Sluderski, R.; Gattuso, P. 2003: Development of second malignancy in conjunction with primary breast cancer; implications for surveillance and prevention. Breast Cancer Research and Treatment 82(Suppl 1): S151
Yoneyama, E.; Sano, Y.; Funada, R.; Yamada, M.; Nakamura, T. 2001: Development of secondary tissue in stem of Prunus jamasakura under simulated microgravity condition. Plant and Cell Physiology 42(Suppl): s112
Haneda, K.; Koyama, T. 2003: Development of secure applications using small medical institutions. Lemke, Heinz U , Reprint Author, Vannier, Michael W, Inamura, Kiyonari, Farman, Allan G, Doi, Kunio, Reiber, John H C Computer assisted radiology and surgery: 1383
Wikfors, G.H.; Widman, J.C.; Smith, B.C.; Veilleux, D.; Choromanski, J.; Meseck, S.L.; Goldberg, R.; Stiles, S. 2004: Development of secure rearing systems for domesticated bivalve broodstock. Journal of Shellfish Research 23(1): 317
Tamamura, H.; Hiramatsu, K.; Omagari, A.; Oishi, S.; Nakashima, H.; Peiper, S.C.; Otaka, A.; Fujii, N. 2002: Development of selective CXCR4 inhibitors with strong anti-HIV activity. Abstracts of Papers American Chemical Society 224(1-2): MEDI 207
Hofmann, T.; Schieberle, P. 2000: Development of selective chemosensors for the on-line process monitoring of coffee roasting. Abstracts of Papers American Chemical Society 220(Part 1): AGFD 103